<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10201436</article-id><article-id pub-id-type="pmid">36951104</article-id><article-id pub-id-type="doi">10.1093/nar/gkad193</article-id><article-id pub-id-type="publisher-id">gkad193</article-id><article-categories><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00010</subject></subj-group><subj-group subj-group-type="heading"><subject>RNA and RNA-protein complexes</subject></subj-group></article-categories><title-group><article-title>Genome-encoded ABCF factors implicated in intrinsic antibiotic resistance in Gram-positive bacteria: VmlR2, Ard1 and CplR</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Obana</surname><given-names>Nozomu</given-names></name><!--obana.nozomu.gb@u.tsukuba.ac.jp--><aff>
<institution>Transborder Medical Research Center, Faculty of Medicine, University of Tsukuba</institution>, <addr-line>Tsukuba</addr-line>, <country country="JP">Japan</country></aff><aff>
<institution>Microbiology Research Center for Sustainability (MiCS), University of Tsukuba</institution>, <addr-line>Tsukuba</addr-line>, <country country="JP">Japan</country></aff><xref rid="COR2" ref-type="corresp"/><xref rid="FN1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Takada</surname><given-names>Hiraku</given-names></name><aff>
<institution>Faculty of Life Sciences, Kyoto Sangyo University</institution>, Motoyama, Kamigamo, Kita-Ku, <addr-line>Kyoto</addr-line>&#x000a0;603-8555, <country country="JP">Japan</country></aff><aff>
<institution>Department of Experimental Medical Science, Lund University</institution>, <addr-line>Lund</addr-line>, <country country="SE">Sweden</country></aff><xref rid="FN1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Crowe-McAuliffe</surname><given-names>Caillan</given-names></name><aff>
<institution>Institute for Biochemistry and Molecular Biology, University of Hamburg</institution>, Martin-Luther-King-Platz 6, 20146&#x000a0;<addr-line>Hamburg</addr-line>, <country country="DE">Germany</country></aff><xref rid="FN1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name><surname>Iwamoto</surname><given-names>Mizuki</given-names></name><aff>
<institution>Faculty of Life and Environmental Sciences, University of Tsukuba</institution>, <addr-line>Tsukuba</addr-line>, <country country="JP">Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Egorov</surname><given-names>Artyom A</given-names></name><aff>
<institution>Department of Experimental Medical Science, Lund University</institution>, <addr-line>Lund</addr-line>, <country country="SE">Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Kelvin J Y</given-names></name><aff>
<institution>Department of Chemistry and Chemical Biology, Harvard University</institution>, <addr-line>Cambridge</addr-line>, <addr-line>MA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3485-3477</contrib-id><name><surname>Chiba</surname><given-names>Shinobu</given-names></name><aff>
<institution>Faculty of Life Sciences, Kyoto Sangyo University</institution>, Motoyama, Kamigamo, Kita-Ku, <addr-line>Kyoto</addr-line>&#x000a0;603-8555, <country country="JP">Japan</country></aff><aff>
<institution>Institute for Protein Dynamics, Kyoto Sangyo University</institution>, <country country="JP">Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Murina</surname><given-names>Victoriia</given-names></name><aff>
<institution>Department of Molecular Biology, Ume&#x000e5; University</institution>, <addr-line>Ume&#x000e5;</addr-line>, <country country="SE">Sweden</country></aff></contrib><contrib contrib-type="author"><name><surname>Paternoga</surname><given-names>Helge</given-names></name><aff>
<institution>Institute for Biochemistry and Molecular Biology, University of Hamburg</institution>, Martin-Luther-King-Platz 6, 20146&#x000a0;<addr-line>Hamburg</addr-line>, <country country="DE">Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Tresco</surname><given-names>Ben I C</given-names></name><aff>
<institution>Department of Chemistry and Chemical Biology, Harvard University</institution>, <addr-line>Cambridge</addr-line>, <addr-line>MA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Nomura</surname><given-names>Nobuhiko</given-names></name><aff>
<institution>Microbiology Research Center for Sustainability (MiCS), University of Tsukuba</institution>, <addr-line>Tsukuba</addr-line>, <country country="JP">Japan</country></aff><aff>
<institution>Faculty of Life and Environmental Sciences, University of Tsukuba</institution>, <addr-line>Tsukuba</addr-line>, <country country="JP">Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Myers</surname><given-names>Andrew G</given-names></name><aff>
<institution>Department of Chemistry and Chemical Biology, Harvard University</institution>, <addr-line>Cambridge</addr-line>, <addr-line>MA</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Atkinson</surname><given-names>Gemma&#x000a0;C</given-names></name><aff>
<institution>Department of Experimental Medical Science, Lund University</institution>, <addr-line>Lund</addr-line>, <country country="SE">Sweden</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3816-3828</contrib-id><name><surname>Wilson</surname><given-names>Daniel N</given-names></name><!--daniel.wilson@chemie.uni-hamburg.de--><aff>
<institution>Institute for Biochemistry and Molecular Biology, University of Hamburg</institution>, Martin-Luther-King-Platz 6, 20146&#x000a0;<addr-line>Hamburg</addr-line>, <country country="DE">Germany</country></aff><xref rid="COR3" ref-type="corresp"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2389-5057</contrib-id><name><surname>Hauryliuk</surname><given-names>Vasili</given-names></name><!--vasili.hauryliuk@med.lu.se--><aff>
<institution>Department of Experimental Medical Science, Lund University</institution>, <addr-line>Lund</addr-line>, <country country="SE">Sweden</country></aff><aff>
<institution>University of Tartu, Institute of Technology</institution>, <addr-line>Tartu</addr-line>, <country country="EE">Estonia</country></aff><aff>
<institution>Science for Life Laboratory</institution>, <addr-line>Lund</addr-line>, <country country="SE">Sweden</country></aff><xref rid="COR1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="COR1">To whom correspondence should be addressed.&#x000a0;Tel: + 46 70 6090493; Email: <email>vasili.hauryliuk@med.lu.se</email></corresp><corresp id="COR2">Correspondence may also be addressed to Nozomu Obana. Tel: +81 298533213;&#x000a0;Email: <email>obana.nozomu.gb@u.tsukuba.ac.jp</email></corresp><corresp id="COR3">Correspondence may also be addressed to Daniel N. Wilson. Tel: +49 40 42838 2841;&#x000a0;Email: <email>daniel.wilson@chemie.uni-hamburg.de</email></corresp><fn id="FN1"><p>The authors wish it to be known that, in their&#x000a0;opinion, the first three authors should be regarded as Joint First Authors.</p></fn></author-notes><pub-date pub-type="collection"><day>22</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-03-23"><day>23</day><month>3</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>3</month><year>2023</year></pub-date><volume>51</volume><issue>9</issue><fpage>4536</fpage><lpage>4554</lpage><history><date date-type="accepted"><day>06</day><month>3</month><year>2023</year></date><date date-type="rev-recd"><day>17</day><month>2</month><year>2023</year></date><date date-type="received"><day>05</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="gkad193.pdf"/><abstract><title>Abstract</title><p>Genome-encoded antibiotic resistance (ARE) ATP-binding cassette (ABC) proteins of the F subfamily (ARE-ABCFs) mediate intrinsic resistance in diverse Gram-positive bacteria. The diversity of chromosomally-encoded ARE-ABCFs is far from being fully experimentally explored. Here we characterise phylogenetically diverse genome-encoded ABCFs from Actinomycetia (Ard1 from <italic toggle="yes">Streptomyces capreolus</italic>, producer of the nucleoside antibiotic A201A), Bacilli (VmlR2 from soil bacterium <italic toggle="yes">Neobacillus vireti</italic>) and Clostridia (CplR from <italic toggle="yes">Clostridium perfringens</italic>, <italic toggle="yes">Clostridium sporogenes</italic> and <italic toggle="yes">Clostridioides difficile</italic>). We demonstrate that Ard1 is a narrow spectrum ARE-ABCF that specifically mediates self-resistance against nucleoside antibiotics. The single-particle cryo-EM structure of a VmlR2-ribosome complex allows us to rationalise the resistance spectrum of this ARE-ABCF that is equipped with an unusually long antibiotic resistance determinant (ARD) subdomain. We show that CplR contributes to intrinsic pleuromutilin, lincosamide and streptogramin A resistance in Clostridioides, and demonstrate that <italic toggle="yes">C. difficile</italic> CplR (CDIF630_02847) synergises with the transposon-encoded 23S ribosomal RNA methyltransferase Erm to grant high levels of antibiotic resistance to the <italic toggle="yes">C. difficile</italic> 630 clinical isolate. Finally, assisted by uORF4u,&#x000a0;our novel tool for detection of upstream open reading frames, we dissect the translational attenuation mechanism that controls the induction of <italic toggle="yes">cplR</italic> expression upon an antibiotic challenge.</p></abstract><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>DFG</institution><institution-id institution-id-type="DOI">10.13039/100004807</institution-id></institution-wrap>
</funding-source><award-id>WI3285/8-1</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Swedish Research Council</institution><institution-id institution-id-type="DOI">10.13039/501100004359</institution-id></institution-wrap>
</funding-source><award-id>2019-01085</award-id><award-id>2017-03783</award-id><award-id>2021-01146</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Estonian Research Council</institution><institution-id institution-id-type="DOI">10.13039/501100002301</institution-id></institution-wrap>
</funding-source><award-id>PRG335</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="DOI">10.13039/100000002</institution-id></institution-wrap>
</funding-source><award-id>R01AI168228</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Centre of Excellence in Molecular Cell Engineering</institution></institution-wrap>
</funding-source><award-id>2014-2020.4.01.15-0013</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Swedish Research Council</institution><institution-id institution-id-type="DOI">10.13039/501100004359</institution-id></institution-wrap>
</funding-source><award-id>2018-00956</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Deutsche Zentrum f&#x000fc;r Luft- und Raumfahrt</institution></institution-wrap>
</funding-source><award-id>DLR01Kl1820</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Knut and Alice Wallenberg Foundation</institution><institution-id institution-id-type="DOI">10.13039/501100004063</institution-id></institution-wrap>
</funding-source><award-id>2020-0037</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Scientific Research</institution></institution-wrap>
</funding-source><award-id>20H05926</award-id><award-id>21K06053</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Institute for Fermentation, Osaka</institution><institution-id institution-id-type="DOI">10.13039/100007802</institution-id></institution-wrap>
</funding-source><award-id>G-2021-2-063</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Scientific Research</institution></institution-wrap>
</funding-source><award-id>21K07018</award-id></award-group></funding-group><counts><page-count count="19"/></counts></article-meta></front><body><sec sec-type="intro" id="SEC1"><title>INTRODUCTION</title><p>Bacterial antimicrobial resistance (AMR) is a constantly growing threat to human health. A 2022 report in <italic toggle="yes">The Lancet</italic> estimated that in 2019 1.27 million deaths were attributable to bacterial AMR globally (<xref rid="B1" ref-type="bibr">1</xref>). One of the primary antibiotic targets is the ribosome (<xref rid="B2" ref-type="bibr">2</xref>), and, accordingly, bacteria protect their protein synthesis machinery via diverse resistance mechanisms (<xref rid="B3" ref-type="bibr">3&#x02013;5</xref>). The functional elements primarily targeted by the antibiotics on the large (50S) ribosomal subunit are the peptidyl transferase centre (PTC) and the nascent polypeptide exit tunnel (NPET) (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B6" ref-type="bibr">6</xref>). The PTC is targeted by numerous antibiotic classes, including (i) nucleoside compounds, such A201A (<xref rid="B7" ref-type="bibr">7</xref>) and hygromycin A (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>), (ii) pleuromutilins, such as tiamulin (<xref rid="B9" ref-type="bibr">9</xref>), (iii) lincosamides, such as the natural compound lincomycin (<xref rid="B10" ref-type="bibr">10</xref>), its semi-synthetic derivative clindamycin (<xref rid="B11" ref-type="bibr">11</xref>) and the fully synthetic antibiotic iboxamycin (<xref rid="B12" ref-type="bibr">12</xref>), (iv) type A streptogramins, such as virginiamycin M1 (<xref rid="B13" ref-type="bibr">13</xref>), (v) phenicols, such as chloramphenicol (<xref rid="B14" ref-type="bibr">14</xref>) and (vi) oxazolidinones, such as linezolid (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). Antibiotics targeting the NPET are represented by macrolides, such as the context-dependent polypeptide elongation inhibitor erythromycin (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>), and by members of the streptogramin B class such as quinupristin (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>The F subfamily of ABC ATPases includes both ribosome-associated antibiotic resistance (ARE) ABCFs (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B20" ref-type="bibr">20</xref>), as well as multiple housekeeping factors that assist protein synthesis and ribosome assembly (<xref rid="B21" ref-type="bibr">21&#x02013;24</xref>). ARE-ABCF factors mediate antibiotic resistance in human pathogens (exemplified by staphylococcal VgaA (<xref rid="B25" ref-type="bibr">25</xref>) and closely related <italic toggle="yes">Listeria monocytogenes</italic> VgaL/Lmo0919 (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>)), in environmental bacteria (exemplified by <italic toggle="yes">B. subtilis</italic> VmlR (<xref rid="B28" ref-type="bibr">28</xref>)), and also confer self-resistance in antibiotic producers (exemplified by <italic toggle="yes">Streptomyces lincolnensis</italic> LmrC (<xref rid="B29" ref-type="bibr">29</xref>)). Expression of ARE-ABCFs is suppressed through abortive transcription termination, with full-length mRNA production and ARE-ABCF expression being induced upon antibiotic-induced ribosomal stalling on a regulatory upstream open reading frame (uORF) that is located in the mRNA region preceding the ARE-ABCF main ORF (<xref rid="B27" ref-type="bibr">27&#x02013;32</xref>).</p><p>ARE-ABCFs are classified into eight relatively well-studied major subfamilies (ARE1 to ARE8) as well numerous poorly characterised phylum-specific groups, such as actinobacterial AAF1-6 (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B33" ref-type="bibr">33</xref>). Members of ARE1-3, ARE5 and ARE6 subfamilies protect the ribosome from PTC-targeting pleuromutilin, lincosamide and streptogramin A (PLS<sub>A</sub>) antibiotics, with the most well-studied ARE-ABCF representatives being ARE1 VgaA and Lmo0919/VgaL, ARE2 VmlR, ARE3 LsaA, ARE5 LmrC&#x000a0;and ARE6 Sal (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B34" ref-type="bibr">34&#x02013;36</xref>). ARE-ABCFs ARE8 PoxtA and ARE7 OptrA protect against phenicol and oxazolidinone (PhO) transpeptidation inhibitors (<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B38" ref-type="bibr">38</xref>). Finally, members of the ARE4 subfamily (such as TlrC) and a subset of ARE1 ABCFs (such as Msr) confer resistance to macrolide and streptogramin B (MS<sub>B</sub>) antibiotics (<xref rid="B39" ref-type="bibr">39&#x02013;41</xref>).</p><p>ABCF ATPases share a common molecular architecture with two ABC nucleotide-binding domains NBD1 and NBD2 connected by an interdomain linker element which is variable in both amino acid sequence and length (<xref rid="B24" ref-type="bibr">24</xref>). This linker is referred to as the antibiotic resistance determinant (ARD) in the case of ARE-ABCFs (<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B42" ref-type="bibr">42</xref>) and as the P-site tRNA-interaction motif (PtIM) in the case of housekeeping ABCFs (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>). The ARD is crucial for displacement of the antibiotic by ARE-ABCFs, and its deletion renders the resistance determinant inactive (<xref rid="B24" ref-type="bibr">24</xref>). Macrolide-resisting factors such as ARE1 MsrE have the longest ARDs which extend into the ribosomal NPET (<xref rid="B41" ref-type="bibr">41</xref>). ARDs of PLS<sub>A</sub>-resisting ARE-ABCF are shorter, as they make contact with the PTC-bound antibiotic and/or induce conformational changes in the PTC that promote antibiotic dissociation (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B43" ref-type="bibr">43</xref>). PhO-resisting PoxtA and OptrA have even shorter ARDs, which act by perturbing the positioning of the CCA-end of the P-site tRNA, rather than directly distorting the PTC (<xref rid="B33" ref-type="bibr">33</xref>). Finally, the P-site tRNA-contacting PtIM elements of the housekeeping ABCFs are in general shorter than the ARD elements of ARE-ABCFs (<xref rid="B21" ref-type="bibr">21&#x02013;23</xref>).</p><p>Antibiotic resistance mediated by ARE-ABCF can synergise with other mechanisms, importantly with resistance mediated by 23S rRNA methylation. This rRNA modification is installed by clinically relevant and widely-spread Erm (Erythromycin resistance methylase) and Cfr (Chloramphenicol and florfenicol resistance) rRNA methyltransferases and confers resistance to macrolide, PhO and PLS<sub>A</sub> antibiotic classes (<xref rid="B44" ref-type="bibr">44&#x02013;47</xref>). Recently we have found that <italic toggle="yes">B. subtilis</italic> ARE-ABCF VmlR can synergise with Cfr to grant significant resistance to lincosamides, including the highly potent fully-synthetic antibiotic iboxamycin (<xref rid="B48" ref-type="bibr">48</xref>). The <italic toggle="yes">cfr</italic> gene is often encoded next to <italic toggle="yes">lsa</italic> ABCF in bacterial pathogens such as <italic toggle="yes">Clostridioides difficile</italic> (formerly <italic toggle="yes">Clostridium difficile</italic>) (<xref rid="B49" ref-type="bibr">49</xref>) and staphylococci (<xref rid="B50" ref-type="bibr">50</xref>), which is supportive of the two resistance determinants cooperating to grant high levels of protection. However, synergy of ARE-ABCFs with Cfr/Erm has not as yet been systematically tested experimentally. Importantly, Erm-mediated resistance is associated with an increased risk of <italic toggle="yes">C. difficile</italic> infection (CDI), and the risk further increases upon clindamycin use (<xref rid="B51" ref-type="bibr">51</xref>). Neither the role of ARE-ABCFs in <italic toggle="yes">C. difficile</italic> resistance, nor potential ARE-ABCF&#x02013;Erm synergy, has been studied.</p><p>To further understand the molecular mechanisms underlying intrinsic antibiotic resistance in Gram-positive bacteria, we have characterised four genome-encoded ARE-ABCF factors. First, we show that well-studied <italic toggle="yes">B. subtilis</italic> ARE2 VmlR mediates resistance to A201A and hygromycin A, which expands the spectrum of ABCF-mediated resistance to nucleoside antibiotics. Second, we characterise the resistance spectrum of a VmlR representative with an unusually long ARD encoded in the genome of soil bacterium <italic toggle="yes">Neobacillus vireti</italic> (formerly <italic toggle="yes">Bacillus vireti</italic>)&#x02014;VmlR2. We rationalise the antibiotic sensitivity data by solving the cryo-EM structure of the VmlR2-70S complex and probe its mechanism through mutagenesis. Third, we demonstrate that actinobacterial AAF1 Ard1 encoded by the A201A producer <italic toggle="yes">Streptomyces capreolus</italic> (<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B53" ref-type="bibr">53</xref>) is a narrow spectrum ARE-ABCF that specifically mediates self-resistance against nucleoside antibiotics. Fourth, we establish Clostridial pleuromutilin and lincosamide resistance protein (CplR) as an ARE1 ABCF resistance factor. We characterise CplR of the important human pathogen <italic toggle="yes">C. difficile</italic> (originally annotated as a multidrug resistance (MDR)-type ABC transporter CDIF630_02847 (<xref rid="B54" ref-type="bibr">54</xref>)), of <italic toggle="yes">Clostridium perfringens</italic>, a common causative agent of food poisoning, as well as of the mutualistic bacterium <italic toggle="yes">Clostridium sporogenes</italic>. We demonstrate that CplR contributes to intrinsic resistance of Clostridioides to lincosamides lincomycin, clindamycin and iboxamycin as well as pleuromutilin retapamulin. While lincosamide resistance mediated by CplR can be overcome by the fully synthetic lincosamide iboxamycin (<xref rid="B12" ref-type="bibr">12</xref>), ARE1 CplR provides high levels of iboxamycin resistance when acting together with transposon-encoded ErmB present in clinically isolated <italic toggle="yes">C. difficile</italic> strain 630 (<xref rid="B55" ref-type="bibr">55</xref>). Given that clindamycin treatment is associated with increased risk of CDI (<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B56" ref-type="bibr">56&#x02013;59</xref>), our discovery and characterisation of CplR-mediated lincosamide resistance mechanism in <italic toggle="yes">C. difficile</italic> is of direct clinical importance.</p></sec><sec sec-type="materials|methods" id="SEC2"><title>MATERIALS AND METHODS</title><sec id="SEC2-1"><title>Sequence and structure analysis</title><p>dRNA-seq and RNAtag-seq data signal tracks (<xref rid="B54" ref-type="bibr">54</xref>) were downloaded from the NCBI GEO (GSE155167) and visualised using svist4get (<xref rid="B60" ref-type="bibr">60</xref>). Searching for conserved short ORFs in 5&#x02032;&#x000a0;leader region sequences of <italic toggle="yes">cplR</italic>, <italic toggle="yes">vmlR</italic> and <italic toggle="yes">vmlR2</italic> was performed with uORF4u [<ext-link xlink:href="https://github.com/GCA-VH-lab/uorf4u" ext-link-type="uri">https://github.com/GCA-VH-lab/uorf4u</ext-link>, <ext-link xlink:href="https://server.atkinson-lab.com/uorf4u" ext-link-type="uri">https://server.atkinson-lab.com/uorf4u</ext-link>] (<xref rid="B61" ref-type="bibr">61</xref>). The pipeline consists of several steps: i) BlastP for homology searching (<xref rid="B62" ref-type="bibr">62</xref>) with cut-offs set on a protein by protein basis to optimise numbers and diversity of hits: 50% sequence identity to the query cutoff for CplR (WP_011861613.1), 70% identity cutoff for VmlR (WP_003234144.1) and VmlR2 (WP_024026878.1) and 80% for LsaA (WP_002398829.1), ii) retrieval of 300 nt upstream sequences preceding the identified ARE-ABCF genes, iii) uORF annotation and, finally, iv) conservation analysis and multiple sequence alignment with MAFFT v7.490 (<xref rid="B63" ref-type="bibr">63</xref>). Visualisation was performed with the ggmsa R package (<xref rid="B64" ref-type="bibr">64</xref>), msa4u (<xref rid="B61" ref-type="bibr">61</xref>) and Logomaker (<xref rid="B65" ref-type="bibr">65</xref>) Python packages. Secondary structures of the <italic toggle="yes">cplR</italic> 5&#x02032;&#x000a0;leader region were predicted using RNAfold (<xref rid="B66" ref-type="bibr">66</xref>) and Mfold (<xref rid="B67" ref-type="bibr">67</xref>). For phylogenetic analysis, selected ARE-ABCFs were aligned with MAFFT v7.490 with the L-INS-i strategy (<xref rid="B63" ref-type="bibr">63</xref>), and visualized with AliView v1.26 (<xref rid="B68" ref-type="bibr">68</xref>) and Jalview v2.11.2.0 (<xref rid="B69" ref-type="bibr">69</xref>). Alignment positions with&#x000a0;&#x0003e;&#x000a0;50% gaps were removed with trimAI v1.4.rev6 (<xref rid="B70" ref-type="bibr">70</xref>) before tree building with IQTree v2.1.2 on the CIPRES server with 1000 rapid bootstrap replicates and the model &#x02018;LG-I-G4&#x02019;, as selected using the automatic model detection setting (<xref rid="B71" ref-type="bibr">71</xref>,<xref rid="B72" ref-type="bibr">72</xref>). For the tree of CplR close relatives, 948 sequences were retrieved from the NCBI RefSeq-Select database using BlastP (<italic toggle="yes">E</italic> value limit 1e<sup>&#x02212;70</sup>, <italic toggle="yes">C. difficile</italic> CplR as the query). The sequences were aligned with MAFFT v7.490 (<xref rid="B63" ref-type="bibr">63</xref>) and phylogenetic analysis carried out with FastTree v 2.1 (<xref rid="B73" ref-type="bibr">73</xref>).</p></sec><sec id="SEC2-2"><title>Bacterial culture</title><p>
<italic toggle="yes">C. difficile</italic> 630&#x00394;<italic toggle="yes">erm</italic> and its derivatives were grown anaerobically in Brain-Heart Infusion (Difco) supplemented with 0.5% yeast extract and 0.1% cysteine (BHIS) or BHIS agar under 80% N<sub>2</sub>, 20% CO<sub>2</sub>, 4% H<sub>2</sub> atmosphere in the Coy anaerobic chamber (COY). <italic toggle="yes">C. sporogenes</italic> and its derivatives were anaerobically grown in Gifu anaerobic medium (GAM) (Nissui Co., Japan) in the Coy anaerobic chamber. <italic toggle="yes">C. perfringens</italic> and its derivatives were grown at 37&#x000b0;C in GAM under anaerobic conditions using Anaeropack system (Mitsubishi Gas Chemical Co. Inc., Tokyo, Japan). <italic toggle="yes">B. subtilis</italic> were routinely aerobically cultured in LB broth. When necessary, antibiotics were supplemented in the media: 20 &#x003bc;g/ml erythromycin and 10 &#x003bc;g/ml thiamphenicol in the case of <italic toggle="yes">C. difficile</italic> and 20 &#x003bc;g/ml chloramphenicol in the case of <italic toggle="yes">C. perfringens</italic>.</p></sec><sec id="SEC2-3"><title>Strain and plasmid construction</title><p>The plasmid and oligonucleotides used in this study are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>, respectively.</p><p>To construct <italic toggle="yes">C. difficile cplR</italic> (CDIF630_02847) deletion mutant we constructed the plasmid for the allele exchange mutagenesis as previously reported by Peltier and colleagues (<xref rid="B67" ref-type="bibr">67</xref>). The CD2517.1 type I toxin gene under the control of the tetracycline-inducible promoter as well as&#x000a0;&#x02248;1&#x02009;kb-long 5&#x02032; and 3&#x02032; flanking regions of the target gene were cloned into pMTL83151 plasmid (CHAIN biotech, Nottingham, UK), yielding the pMSRNO plasmid. Using <italic toggle="yes">E. coli</italic> HB101/pRK24, the pMSRNO plasmid was then introduced into <italic toggle="yes">C. difficile</italic> by conjugation. pRK24 (<xref rid="B74" ref-type="bibr">74</xref>) was a gift from Farren Isaacs (Addgene plasmid # 51950). Briefly, 500 &#x003bc;l of overnight cultured <italic toggle="yes">C. difficile</italic> were heated at 52&#x000b0;C for 2 min. Meanwhile, 1 ml culture of <italic toggle="yes">E. coli</italic> HB101/pRK24 harbouring pNO201 were centrifuged and pelleted at 1500&#x000a0;&#x000d7;&#x000a0;<italic toggle="yes">g</italic> for 3 min. The <italic toggle="yes">E. coli</italic> pellet was suspended to 200 &#x003bc;l of the heated <italic toggle="yes">C. difficile</italic> culture in the anaerobic chamber. The mixture was spotted onto a BHI agar plate and incubated for 8 h. The mixed colonies were resuspended in 1 ml BHI broth, and then spread onto BHIS plates supplemented with 10 &#x003bc;g/ml thiamphenicol, 250 &#x003bc;g/ml <sc>d</sc>-cycloserine and 50 &#x003bc;g/ml kanamycin (BHIS-TCK). After incubation for two to three days, individual colonies were restreaked on BHIS-TCK for isolation. The protocol for allele exchange was based on that of Peltier and colleagues (<xref rid="B67" ref-type="bibr">67</xref>). The deletion of the target gene was confirmed by PCR amplification.</p><p>
<italic toggle="yes">C. sporogenes</italic> mutants were constructed using the Targetron system (Merck). A DNA fragment containing group II intron and <italic toggle="yes">ltrA</italic> gene from pJIR750ai (Merck) as well as a <italic toggle="yes">Clostridium-E. coli</italic> shuttle vector pMTL83153 (CHAIN biotech, Nottingham, UK) containing a constitutive promoter P<italic toggle="yes"><sub>fdx</sub></italic> were PCR-amplified, and the intron-containing plasmid was produced by ligation of these DNA fragments pre-digested with <italic toggle="yes">Hind</italic>III and <italic toggle="yes">Xho</italic>I. Then, a PCR-amplified <italic toggle="yes">C. sporogenes cplR</italic>-targeted intron was introduced into <italic toggle="yes">Hind</italic>III-<italic toggle="yes">BsrG</italic>I site in the plasmid. The resulting pNO201 plasmid was used for <italic toggle="yes">cplR</italic> mutant construction. The pNO201 plasmid was introduced into <italic toggle="yes">C. sporogenes</italic> by conjugation as described above, with one modification: the heat treatment prior to conjugation was omitted. While this step is crucial for obtaining transconjugants with <italic toggle="yes">C. difficile</italic>, in the case of <italic toggle="yes">C. sporogenes</italic> transconjugants are easily obtained without heat shock. To screen the mutant in which the target gene was disrupted, the colonies were restreaked onto BHIS containing 20 &#x003bc;g/ml erythromycin. The insertion of the intron in the appropriate locus was verified by PCR amplification.</p><p>The <italic toggle="yes">C. perfringens</italic> mutant was constructed as described previously (<xref rid="B75" ref-type="bibr">75</xref>,<xref rid="B76" ref-type="bibr">76</xref>). Briefly, &#x02248;1&#x02009;kb of the 5&#x02032; and 3&#x02032; flanking regions of the target gene were PCR-amplified, and the resultant fragments were cloned into pCM-GALK using the In-Fusion cloning system (Takara Bio, Japan). Resulting plasmid was introduced into <italic toggle="yes">C. perfringens</italic> HN13 via electroporation, and the desired mutant was isolated on agar plates supplemented with 20&#x02009;&#x003bc;g/ml chloramphenicol or 3% galactose. The deletion of the target gene was confirmed by PCR and DNA sequencing.</p><p>For complementation of <italic toggle="yes">cplR</italic> genes in <italic toggle="yes">C. difficile</italic> and <italic toggle="yes">C. perfringens</italic>, <italic toggle="yes">cplR</italic>-expressing plasmids were constructed. The <italic toggle="yes">C. difficile cplR</italic>-expressing plasmid was based on pRPF185 plasmid which contains a tetracycline-inducible promoter (<xref rid="B77" ref-type="bibr">77</xref>). The pRPF185 was a gift from Robert Fagan and Neil Fairweather (Addgene plasmid # 106367; <ext-link xlink:href="http://n2t.net/addgene:106367;" ext-link-type="uri">http://n2t.net/addgene:106367;</ext-link><ext-link xlink:href="https://scicrunch.org/resolver/RRID:" ext-link-type="uri">RRID:</ext-link> Addgene_106367). A PCR-amplified <italic toggle="yes">cplR</italic> CDS was cloned into pRFP185 using the In-Fusion cloning system. For complementation of <italic toggle="yes">C. perfringens cplR</italic>, the DNA fragment containing a native promoter and CDS of <italic toggle="yes">C. perfringens cplR</italic> gene was amplified by PCR and cloned into pJIR750 (<xref rid="B78" ref-type="bibr">78</xref>).</p><p>An <italic toggle="yes">mCherry2-L</italic> variant codon-optimized for low-GC bacteria was used to construct the reporter constructs used to assay the regulation of <italic toggle="yes">cplR</italic> expression (<xref rid="B79" ref-type="bibr">79</xref>). The DNA fragment encoding a codon-optimized <italic toggle="yes">mCherry2-L</italic> CDS was synthesized at Eurofin Genomics (Tokyo, Japan). DNA fragments containing <italic toggle="yes">cplR</italic> promoter and 5&#x02032; leader region were amplified and ligated with the <italic toggle="yes">mCherry2-L</italic> by PCR. The resulting DNA was introduced into pMTL84151 (CHAIN biotech) using the In-Fusion cloning system.</p><p>The <italic toggle="yes">B. subtilis</italic> strains were derivatives of wt168 (<italic toggle="yes">trpC2</italic>). The strains were constructed through homologous recombination by transformation with plasmids listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>. The plasmids were constructed by standard cloning methods including PCR and Gibson assembly using oligonucleotides listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>. Successful integration of a gene into the chromosome was accomplished by double crossing-over at the target loci. The resulting recombinant clones were checked for their antibiotic resistance markers, including the absence of those originally present on the plasmid backbone, as well as for inactivation of the <italic toggle="yes">thrC</italic> target locus.</p></sec><sec id="SEC2-4"><title>Antibiotic susceptibility testing</title><p>The Minimum Inhibitory Concentrations (MIC) were calculated according to guidelines from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (<ext-link xlink:href="http://www.eucast.org/ast_of_bacteria/mic_determination" ext-link-type="uri">http://www.eucast.org/ast_of_bacteria/mic_determination</ext-link>). Bacterial cells were cultured in 96-well plates in medium supplemented with 2-fold serial dilutions of the antibiotics. BHIS, GAM, or LB media was used to grow <italic toggle="yes">C. difficile</italic>, <italic toggle="yes">C. perfringens</italic>/<italic toggle="yes">C. sporogenes</italic> and <italic toggle="yes">B. subtilis</italic>, respectively. The 200 &#x003bc;l cultures were inoculated at the concentration of 5&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup> CFU/ml and grown&#x000a0;in the 96-well plates. The MIC was determined as the lowest concentration of antibiotics in which no bacterial growth was observed after incubation for 24 h&#x000a0;at 37&#x000b0;C. The reproducibility was confirmed by at least three individual experiments.</p></sec><sec id="SEC2-5"><title>Immunoprecipitation of C-terminally HTF-tagged VmlR2<sub>N.vireti</sub><sup>EQ2</sup></title><p>The experiments were performed as described earlier (<xref rid="B26" ref-type="bibr">26</xref>). C-terminally HTF-tagged VmlR2<italic toggle="yes"><sub>N.vireti</sub></italic><sup>EQ2</sup> inducible strain VHB220 (&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spnak</sub></italic>-<italic toggle="yes">vmlR2<sub>B.vireti</sub></italic><sup>EQ2</sup><italic toggle="yes">-HTF</italic>; HTF stands for His<sub>6</sub>-TEV-FLAG<sub>3</sub>) was pre-grown on LB plates overnight at 30&#x000b0;C. Fresh individual colonies were used for inoculation and grown in LB medium with 1 mM IPTG. 0.5 l cultures were grown at 37&#x000b0;C to OD<sub>600</sub> = 0.8. Cells were collected by centrifugation (8000 rpm for 10 min at 4&#x000b0;C, JLA-16.25 Beckman Coulter rotor), pellets were&#x000a0;frozen in liquid nitrogen and stored at &#x02013;80&#x000b0;C. Cell pellets were resuspended in 1 ml of cell opening buffer (95 mM KCl, 5 mM NH<sub>4</sub>Cl, 20 mM HEPES (pH 7.5), 1 mM DTT, 15 mM Mg(OAc)<sub>2</sub>, 0.5 mM CaCl<sub>2</sub>, 8 mM putrescine, 1 mM spermidine, 1 tablet of cOmplete&#x02122; EDTA-free Protease Inhibitor Cocktail (Roche) per 50 ml of buffer) and disrupted using FastPrep homogeniser (MP Biomedicals) with 0.1 mm Zirconium beads (Techtum) in 6 cycles by 20 s&#x000a0;with 3-min&#x000a0;chilling on ice. Cell debris was removed by centrifugation at 14&#x000a0;800 rpm for 20 min&#x000a0;4&#x000b0;C in F241.5P rotor using 149 Microfuge 22R centrifuge (Beckman Coulter). The supernatant was combined with 100 &#x003bc;l of ANTI-FLAG M2 Affinity Gel (Sigma) pre-equilibrated in cell opening buffer, and incubated for 1.5 h&#x000a0;at 4&#x000b0;C on a turning wheel (Fisherbrand&#x02122; Multi-Purpose Tube Rotators). The samples were loaded on Micro Bio-Spin columns (Bio-Rad) pre-equilibrated in cell opening buffer, and washed 5 times with 0.5 ml of cell opening buffer by gravity flow. VmlR2<italic toggle="yes"><sub>vireti</sub></italic><sup>EQ2</sup>-HTF was eluted by addition of 200 &#x003bc;l opening buffer containing 0.1 mg/ml poly-FLAG peptide (Biotool, Bimake) for 45 min on a turning wheel. All incubations, washes and elutions were performed at 4&#x000b0;C. The eluted sample was collected by centrifugation at 2000 rpm for 1 min&#x000a0;4&#x000b0;C in a F241.5P rotor using a 149 Microfuge 22R centrifuge (Beckman Coulter). For SDS-PAGE analyses, 20 &#x003bc;l aliquots of samples were mixed with 5 &#x003bc;l of 5&#x000d7;&#x000a0;SDS loading buffer and heated at 95&#x000b0;C for 15 min, and denatured samples were loaded on 12% SDS-PAGE. SDS-gels were stained by &#x02018;Blue-Silver&#x02019; Coomassie Staining (<xref rid="B80" ref-type="bibr">80</xref>) and washed with water for 6 h&#x000a0;before imaging with LAS4000 (GE Healthcare) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>).</p></sec><sec id="SEC2-6"><title>Preparation of cryo-EM grids</title><p>Elutions from pull-downs were kept on ice until being applied within two h to glow discharged cryo-grids (Quantifoil 2/2 Cu<sub>300</sub> coated with 2 nm continuous carbon). 3.5 &#x003bc;l of sample was loaded on grids in Vitrobot (FEI) under conditions of 100% humidity at 4&#x000b0;C, blotted for 5 s&#x000a0;and vitrified by plunge-freezing in liquid ethane. Samples were imaged on a Titan Krios (FEI) operated at 300 kV at a nominal magnification of 165&#x000a0;000&#x000d7;&#x000a0;(0.82 &#x000c5;/pixel) with a Gatan K2 Summit camera and a BioQuantum energy filter with a slit width of 20 eV. The exposure rate was 5.277 electrons/pixel/s with a 4 second exposure and 20 frames using the EPU software.</p></sec><sec id="SEC2-7"><title>Cryo-EM data analysis</title><p>MotionCor2 was used to correct for beam-induced motion in 6384 starting micrographs (<xref rid="B81" ref-type="bibr">81</xref>). Contrast transfer functions were estimated with Gctf (<xref rid="B82" ref-type="bibr">82</xref>). Subsequent processing was performed in RELION 3.1 unless specified otherwise (<xref rid="B83" ref-type="bibr">83</xref>,<xref rid="B84" ref-type="bibr">84</xref>). Micrographs with MaxRes&#x000a0;&#x0003e;4 &#x000c5; and/or a CtfFigureOfMerit&#x000a0;&#x0003c;0.05 were discarded, resulting in 5014 micrographs used for further processing. From the resulting set of 5&#x000a0;014 micrographs, 279&#x000a0;082 particles were picked with Gautomatch [<ext-link xlink:href="https://www2.mrc-lmb.cam.ac.uk/download/gautomatch-056" ext-link-type="uri">https://www2.mrc-lmb.cam.ac.uk/download/gautomatch-056</ext-link>] and extracted with a pixel size of 2.46 &#x000c5;. 2D classification was used to remove non-ribosomal particles, resulting in 193&#x000a0;343 particles which were subjected to 3D auto refinement. The initial reference, which was low-pass filtered to 60 &#x000c5;, was a <italic toggle="yes">B. subtilis</italic> 70S ribosome that contained a P-tRNA and no factor in the E site (EMD-0176, (<xref rid="B34" ref-type="bibr">34</xref>)). The output volume was used as a reference for subsequent 3D refinements. 3D classification with four classes and without angular sampling was then performed, resulting in two classes of interest that contained density in the E site. The best-resolved of the two classes, class 2, was used for most analyses, on the grounds that this class had the most continuous and feature-rich density for the protein in the E site. Particles from class 2 were re-extracted at the original pixel size and used for 3D autorefinement, and then anisotropic magnification, per-particle defocus, per-micrograph astigmatism, beam tilt, and higher-order aberrations were refined before final 3D autorefinement and post-processing (<xref rid="B84" ref-type="bibr">84</xref>).</p><p>A combined volume, containing particles from both classes with VmlR2 density in the E site, was also re-extracted as above and partial signal subtraction followed by 3D classification around the A and E sites was performed. For the A-site classification, three classes with 29.1%, 37.6%&#x000a0;and 33.3% occupancy were observed. The first and last of these classes contained a tRNA, each in a slightly different conformation, while the second class had no density in the A site, consistent with the poorly resolved density for the A tRNA in the parent map. Each of these classes was reverted to full density and used for 3D autorefinement. Partial signal subtraction and 3D classification around the E site and L1 stalk yielded three maps that differed mostly in the conformation of the L1 stalk, consistent with the poor resolution of this region in the parent map. However, density for VmlR2 was not improved in any of these classes, so class 2 from the initial 3D classification was used for further analyses.</p><p>For post-processing, soft solvent masks and a <italic toggle="yes">B</italic> factor automatically estimated by Guinier analysis were used. See also <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref> for an overview of processing and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 2</xref> for collection and processing statistics.</p></sec><sec id="SEC2-8"><title>Model building and refinement</title><p>Starting models for <italic toggle="yes">B. subtilis</italic> ribosomal proteins and VmlR2 were obtained from the AlphaFold2 database (<xref rid="B85" ref-type="bibr">85</xref>). Ribosomal RNA was taken from PDB 6HA1 (<xref rid="B34" ref-type="bibr">34</xref>). Models were first adjusted using Coot (<xref rid="B86" ref-type="bibr">86</xref>) into a high-resolution <italic toggle="yes">B. subtilis</italic> 70S map (to be described elsewhere). The resulting model was then fitted in the VmlR2-70S map and adjusted manually with Coot. The starting model of VmlR2 was fitted domain-by-domain and adjusted by hand. A prediction created by ModelAngelo was also used to guide modelling of VmlR2 in places (<xref rid="B87" ref-type="bibr">87</xref>). For the P-site tRNA and 23S rRNA of the L1 stalk, PDBs 7NHK and 7NHL were used as starting points, respectively (<xref rid="B26" ref-type="bibr">26</xref>). Density for the uL1 protein and the CCA-3&#x02032; end nucleotides of the P-site tRNA was very unclear and these regions were therefore omitted from the model. PDB 7K00 was used as a reference to guide modelling, especially around 23S rRNA helix 69 (<xref rid="B88" ref-type="bibr">88</xref>). The resulting model was refined first with REFMAC5/Servalcat (<xref rid="B89" ref-type="bibr">89</xref>,<xref rid="B90" ref-type="bibr">90</xref>), then with Phenix using the starting model as a reference for restraints to decrease bond length and angle root-mean-square deviations (<xref rid="B91" ref-type="bibr">91</xref>). MolProbity through Phenix was used for model validation (<xref rid="B92" ref-type="bibr">92</xref>). Model statistics are available in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 2</xref>. Figures showing maps and models were made with UCSF ChimeraX (<xref rid="B93" ref-type="bibr">93</xref>) or PyMOL (<ext-link xlink:href="https://github.com/schrodinger/pymol-open-source" ext-link-type="uri">https://github.com/schrodinger/pymol-open-source</ext-link>).</p></sec><sec id="SEC2-9"><title>RNA extraction and RT-PCR</title><p>Overnight culture 630&#x00394;<italic toggle="yes">erm C. difficile</italic> strain in BHIS was diluted 1:20 in fresh BHIS medium and incubated anaerobically for 2 h to reach the log phase. Then we added various concentrations of antibiotics to the culture. After incubation for 0.5&#x02013;6 h, the cells were collected from 1 ml of the culture by centrifugation at 10&#x000a0;000&#x000a0;&#x000d7;&#x000a0;<italic toggle="yes">g</italic> for 2 min and flash frozen in liquid nitrogen. Total RNAs were extracted as described previously (<xref rid="B94" ref-type="bibr">94</xref>) with minor modifications. Briefly, the cell pellets were flash-frozen in liquid nitrogen until use. The cells were resuspended in 500 &#x003bc;l of LETS buffer (100 mM LiCl, 20 mM EDTA, 20 mM Tris&#x02013;HCl pH&#x000a0;8.0, 1% SDS) and disrupted by addition of 500 &#x003bc;l of glass beads and 500 &#x003bc;l of phenol/chloroform/isoamylalchol followed by shaking for 5 min using a Shake Master NEO (Bio Medical Science, Tokyo, Japan). After centrifugation at 20&#x000a0;000&#x000a0;&#x000d7;&#x000a0;<italic toggle="yes">g</italic> for 5 min, the aqueous layer was transferred to a fresh tube and mixed with equal volume of phenol/chloroform/isoamylalchol. To recover the total RNAs, the aqueous layer was mixed with 2.5 volumes of ethanol and 0.1 volumes of 3 M NaOAc, pH&#x000a0;5.2. The RNA was harvested by centrifugation at 20&#x000a0;000&#x000a0;&#x000d7;&#x000a0;<italic toggle="yes">g</italic> for 10 min, washed with 70% ethanol, and contaminated DNA was removed by DNase I treatment (Promega). Purified RNA samples were resuspended in 50 &#x003bc;l of RNase-free water and stored at &#x02212;80&#x000b0;C.</p><p>Reverse transcription was preformed with PrimeScript&#x02122; RT Master Mix kit (TaKaRa, Japan) using 10&#x000a0;or 0.5 ng (genomic or plasmid encoding genes, respectively) of total RNA. The cDNAs for the target genes were amplified using Tks Gflex&#x02122; DNA Polymerase (TaKaRa, Japan) and the primers used are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>.</p></sec><sec id="SEC2-10"><title>mCherry fluorescent reporter assays</title><p>
<italic toggle="yes">C. difficile</italic> harbouring reporter plasmids were cultured in BHIS supplemented with 10 &#x003bc;g/ml thiamphenicol. Cells were harvested from 1 ml cultures by centrifugation at 10&#x000a0;000&#x000a0;&#x000d7;&#x000a0;<italic toggle="yes">g</italic> for 2 min and washed with phosphate buffer saline (PBS). The resultant cell pellets were fixed with 4% formaldehyde for 8 min, washed with PBS and resuspended in 1 ml of PBS. After exposure to oxygen for 90 min for chromophore maturation, fluorescence (ex/em&#x000a0;=&#x000a0;579/616 nm) and absorbance (600 nm) of each sample were measured using a Synergy H1 microplate reader (BioTek, Vermont, USA). To calculate the relative promoter activity, relative fluorescence intensity normalised by O.D.<sub>600</sub> was further normalised by the signal from the constitutive P<italic toggle="yes"><sub>fdx</sub>-mCherry</italic> reporter.</p></sec></sec><sec sec-type="results" id="SEC3"><title>RESULTS</title><sec id="SEC3-1"><title>The ABCF ARE1 subfamily member CplR is conserved in Clostridia</title><p>While horizontally mobile ARE-ABCFs that are encoded in mobile genetic elements or plasmids mediate acquired antibiotic resistance, chromosomally-encoded ARE-ABCFs provide intrinsic antibiotic resistance and are likely to be predominantly inherited vertically. The three Gram-positive ARE-ABCF representatives characterised here&#x02014;CplR (standing for <underline>C</underline>lostridial <underline>p</underline>leuromutilin and <underline>l</underline>incosamide <underline>r</underline>esistance; we propose this new name based on the resistance spectrum determined in the current study, see below), VmlR2 and Ard1&#x02014;are of the latter, intrinsic type. Despite this commonality, they belong to very different subfamilies of the ABCF family tree (Figure <xref rid="F1" ref-type="fig">1A</xref>). <italic toggle="yes">C. difficile</italic> CplR encoded by the gene CDIF630_02847 (RefSeq protein accession WP_011861613.1) is a member of the ARE1 subfamily, although it is phylogenetically distinct from the well-characterised mobile Vga- and Msr-like ARE1 proteins. CplR is found in a range of different Clostridia, including <italic toggle="yes">C. difficile</italic>, <italic toggle="yes">C. perfringens</italic> and <italic toggle="yes">C. sporogenes</italic> (Figure <xref rid="F1" ref-type="fig">1A</xref>). The core CplR group is found in various clostridia genera: <italic toggle="yes">Terrisporobacter</italic>, <italic toggle="yes">Clostridium</italic>, <italic toggle="yes">Clostridoides</italic> and <italic toggle="yes">Paeniclostridia</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3</xref>). However, there is a large diversity of CplR close relatives in bacillota, for which it is hard to establish orthology versus paralogy. The ARE2 subfamily of ABCFs can be subdivided into two phylogenetically distinct types: one subtype has a short &#x02018;arm&#x02019; subdomain, as is seen in VmlR from <italic toggle="yes">B. subtilis</italic> (<xref rid="B34" ref-type="bibr">34</xref>), while the second form has insertions in the arm and &#x02013; sometimes &#x02013; the ARD/linker element, as is the case with <italic toggle="yes">Neobacillus vireti</italic> VmlR2 (Figure <xref rid="F1" ref-type="fig">1B</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S4</xref>). The Ard1 ABCF from <italic toggle="yes">Streptomyces capreolus</italic> is classified as being in the actinobacterial subfamily AAF1, closely related to ARE4 and ARE5 subfamilies (<xref rid="B24" ref-type="bibr">24</xref>). Just as with <italic toggle="yes">C. difficile</italic> CplR ARE-ABCF (<xref rid="B54" ref-type="bibr">54</xref>), Ard1 was originally mis-annotated as a transporter (<xref rid="B52" ref-type="bibr">52</xref>). While ABCF proteins do carry the ATP-binding cassette domain that is also found in many transmembrane transporters, they lack the necessary transmembrane domains for such a role. Ard1 is encoded as part of the A201A antibiotic biosynthesis gene cluster, acting as a self-resistance determinant (<xref rid="B53" ref-type="bibr">53</xref>).</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Maximum likelihood phylogenetic analysis of selected ABCFs places CplR, Ard1 and VmlR2 in different clades of the ABCF family tree. (<bold>A</bold>) Branches are proportional to the number of amino acid substitutions according to the lower left legend. Branch support values are percentage Ultrafast Bootstrap Support values, in percentages. Only those 50% or higher are shown. CplR is a member of the ARE1 subfamily, but without any strongly supported specific association with Vga or Msr subtypes. There is strong support for Ard1 falling within the same clade as other actinomycete ARE subfamilies, all of which likely confer self-protection of the antibiotic producer. VmlR2 is a close relative of VmlR, but has distinctive sequence/structure features, including (<bold>B</bold>) an extended ARD/linker subdomain (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S4</xref> for full alignment).</p></caption><graphic xlink:href="gkad193fig1" position="float"/></fig></sec><sec id="SEC3-2"><title>Antibiotic resistance spectra of <italic toggle="yes">S. capreolus</italic> AAF1 Ard1, <italic toggle="yes">N. vireti</italic> ARE2 VmlR2, <italic toggle="yes">C. dfficile</italic> ARE1 CplR expressed in <italic toggle="yes">B. subtilis</italic> &#x00394;<italic toggle="yes">vmlR</italic> surrogate host</title><p>To determine the spectra of antibiotic resistance conferred by <italic toggle="yes">N. vireti</italic> VmlR, <italic toggle="yes">S. capreolus</italic> Ard1, and <italic toggle="yes">C. difficile</italic> CplR, we first ectopically expressed these ARE-ABCFs in a <italic toggle="yes">B. subtilis</italic> surrogate host under the control of an IPTG-inducible P<italic toggle="yes"><sub>hy-spank</sub></italic> promoter (<xref rid="B95" ref-type="bibr">95</xref>) and determined the Minimum Inhibitory Concentrations (MICs) for a comprehensive panel of translation-targeting antibiotics (Table <xref rid="tbl1" ref-type="table">1</xref>). We used a <italic toggle="yes">B. subtilis</italic> strain lacking the VmlR ARE-ABCF factor since the &#x00394;<italic toggle="yes">vmlR</italic> strain is highly sensitive to PLS<sub>A</sub> antibiotics (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B48" ref-type="bibr">48</xref>).</p><table-wrap position="float" id="tbl1"><label>Table 1.</label><caption><p>MICs of nucleoside, PLS<sub>A</sub> and phenicol antibiotics against <italic toggle="yes">B. subtilis</italic> strains</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="9" align="center" rowspan="1">MIC (&#x003bc;g/ml)</th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">B. subtilis</italic> strain</th><th rowspan="1" colspan="1">A201A</th><th rowspan="1" colspan="1">Hygromycin A</th><th rowspan="1" colspan="1">Repatamulin</th><th rowspan="1" colspan="1">Tiamulin</th><th rowspan="1" colspan="1">Lincomycin</th><th rowspan="1" colspan="1">Iboxamycin</th><th rowspan="1" colspan="1">Virginiamycin M1</th><th rowspan="1" colspan="1">Chloramphenicol</th><th rowspan="1" colspan="1">Erythromycin</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">168 wt</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR</italic></td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3 -0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank-</sub>vmlR</italic></td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;2</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR<sup>EQ2</sup></italic></td><td rowspan="1" colspan="1">2&#x02013;4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3&#x02013;0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic></td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic> -HTF</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>EQ2</sup>-HTF</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3&#x02013;0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>R259A</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>Q260A</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>I261A</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>I261G</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;1.25</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N.vireti</sub></italic><sup>E265A</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;1.25</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N</sub>.<sub>vireti</sub></italic><sup>Y266A</sup></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">vmlR2<sub>N</sub>.<sub>vireti</sub></italic><sub>&#x00394;254&#x02013;261 (&#x00394;SASERRQI)</sub></td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank-</sub>ard1</italic></td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3&#x02013;0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>-<italic toggle="yes">ard1<sup>EQ2</sup></italic></td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3&#x02013;0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>- <italic toggle="yes">cplR<sup>Cd</sup></italic></td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">&#x0003e;80</td><td rowspan="1" colspan="1">1&#x02013;2</td><td rowspan="1" colspan="1">&#x0003e;64</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hy-spank</sub></italic>- <italic toggle="yes">cplR<sup>Cd</sup>-FLAGx3</italic></td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.3&#x02013;0.6</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">N.D.</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">N.D.</td></tr></tbody></table><table-wrap-foot><fn id="T1TFN1"><p>
<italic toggle="yes">B. subtilis</italic> MIC testing was carried out in either LB medium (168 wt and &#x00394;<italic toggle="yes">vmlR</italic> strains) or LB supplemented with 1 mM IPTG added to induce expression of ARE-ABCF proteins (all the other strains), and growth inhibition was scored after 16&#x02013;20 h at 37&#x000b0;C. N.D. stands for &#x02018;not determined&#x02019;.</p></fn></table-wrap-foot></table-wrap><p>While the wild-type <italic toggle="yes">B. subtilis</italic> is virtually immune to A201A and hygromycin A (MICs in excess of 256 &#x003bc;g/ml, beyond the concentration levels that are experimentally feasible given the paucity of these antibiotics), the &#x00394;<italic toggle="yes">vmlR</italic> strain is sensitive (MIC for A201A of 4 &#x003bc;g/ml, MIC for hygromycin A of 16 &#x003bc;g/ml) (Table <xref rid="tbl1" ref-type="table">1</xref>). This observation expands the spectrum of known VmlR-mediated resistance to nucleoside compounds. When <italic toggle="yes">B. subtilis</italic> VmlR is overexpressed in &#x00394;<italic toggle="yes">vmlR B. subtilis</italic>, the strain becomes PLS<sub>A</sub>- and nucleoside-resistant; no protective effect is detectable when an ATPase-deficient EQ<sub>2</sub> variant of VmlR is expressed (Table <xref rid="tbl1" ref-type="table">1</xref>). Expression of <italic toggle="yes">N. vireti</italic> VmlR2 confers the same PLS<sub>A</sub> and nucleoside resistance spectrum, despite the relatively long ARD, without any detectable resistance to macrolides (Table <xref rid="tbl1" ref-type="table">1</xref>). Expression of <italic toggle="yes">S. capreolus</italic> Ard1 in <italic toggle="yes">Streptomyces lividuns</italic> is known to confer resistance to A201 (<xref rid="B52" ref-type="bibr">52</xref>), however no systematic characterisation of the Ard1 resistance spectrum was performed. The P<italic toggle="yes"><sub>hy-spank</sub></italic>-driven expression of wild-type <italic toggle="yes">S. capreolus</italic> Ard1&#x02014;but not that of EQ<sub>2</sub> Ard1&#x02014;confers &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> moderate resistance to nucleoside&#x02014;but not PLS<sub>A</sub>&#x02014;antibiotics. The narrow spectrum of Ard1-mediated resistance suggests that Ard1 specifically confers self-resistance to A201A (Table <xref rid="tbl1" ref-type="table">1</xref>). Finally, ectopic expression of <italic toggle="yes">C. difficile</italic> CplR confers &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> resistance to PLS<sub>A</sub> antibiotics and has a moderate (2- to 4-fold increase in MIC) protective effect against nucleosides.</p><p>Collectively, these results&#x000a0;(i) expand the resistance spectrum of ABCF-mediated resistance to nucleoside antibiotics, (ii) demonstrate that despite its relatively long ARD, <italic toggle="yes">N. vireti</italic> ARE2 VmlR has a PLS<sub>A</sub> and nucleoside resistance spectrum identical to that of the short-ARD <italic toggle="yes">B. subtilis</italic> ARE2 VmlR, (iii) establish <italic toggle="yes">S. capreolus</italic> Ard1 ARE-AAF1 as a dedicated narrow-spectrum nucleoside resistance factor and (iv) establish genome-encoded <italic toggle="yes">C. difficile</italic> ARE1 CplR as a PLS<sub>A</sub> resistance determinant.</p></sec><sec id="SEC3-3"><title>Cryo-EM structure of <italic toggle="yes">N. vireti</italic> VmlR2-70S complex</title><p>Next, we aimed to determine cryo-electron microscopy structures of ribosome-bound ATPase-deficient (EQ<sub>2</sub>) <italic toggle="yes">C. difficile</italic> ARE1 CplR and <italic toggle="yes">N. vireti</italic> ARE2 VmlR2. To generate the ribosome-bound complexes we employed our well-established affinity purification strategy (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B33" ref-type="bibr">33</xref>). While the <italic toggle="yes">C. difficile</italic> CplR structure would provide the necessary structural insights into intrinsic PLS<sub>A</sub> and nucleoside antibiotic resistance of <italic toggle="yes">C. difficile</italic> pathogen, the <italic toggle="yes">N. vireti</italic> VmlR structure would be instructive for structural rationalisation of the VmlR2<italic toggle="yes"><sub>N.vireti</sub></italic>&#x000a0;resistance spectrum that is identical to that of short-ARD <italic toggle="yes">B. subtilis</italic> VmlR. <italic toggle="yes">S. capreolus</italic> Ard1 has not been prioritised for structural studies for two reasons: (i) the lack of established genetic tools for <italic toggle="yes">S. capreolus</italic> and (ii) the levels of nucleoside antibiotic resistance conferred in <italic toggle="yes">B. subtilis</italic> surrogate host are modest, indicative of imperfect functioning of the resistance determinant on the <italic toggle="yes">B. subtilis</italic> 70S ribosome.</p><p>Unfortunately, our attempts to purify the FLAG<sub>3</sub>-tagged <italic toggle="yes">C. difficile</italic> CplR in complex with the ribosome were unsuccessful. As C-terminal FLAG<sub>3</sub>-tagging of <italic toggle="yes">C. difficile</italic> CplR abrogated the functionality of CplR in &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> (Table <xref rid="tbl1" ref-type="table">1</xref>; &#x00394;<italic toggle="yes">vmlR thrC</italic>::P<italic toggle="yes"><sub>hyspank</sub></italic>-<italic toggle="yes">cplR<sup>Cd</sup>-FLAG<sub>3</sub></italic>), we did not pursue this direction further. However, we were successful in isolating a complex of EQ<sub>2</sub><italic toggle="yes">N. vireti</italic> VmlR2-HTF with <italic toggle="yes">B. subtilis</italic> 70S ribosomes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). The immunoprecipitated FLAG<sub>3</sub>-tagged EQ<sub>2</sub> VmlR2 was eluted and applied to a cryo-EM grid for imaging in a Titan Krios followed by single-particle analysis using RELION (<xref rid="B83" ref-type="bibr">83</xref>). Three-dimensional classification revealed one major class of particles (72.3% of particles after 2D classification) consisting of VmlR2-EQ<sub>2</sub> bound to the 70S ribosome (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>). This volume could be refined to an average resolution of 2.9 &#x000c5; (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5A,&#x000a0;B</xref>). The VmlR2 NBDs and C-terminal extension (CTE) could be modelled by domain-wise fitting and adjustment of the AlphaFold2 model (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5C</xref>). While the density for the NBDs was not sufficient to draw conclusions about the precise geometry adopted by the catalytic region of the enzyme, the VmlR2 interdomain linker, consisting of two &#x003b1; helices and a loop, and which extends into the core of the large ribosomal subunit, was well resolved and could be modelled <italic toggle="yes">de novo</italic> with high confidence (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5C</xref>). The VmlR2-70S structure is globally similar to other antibiotic resistance ABCF-70S complexes (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B43" ref-type="bibr">43</xref>) (Figure <xref rid="F2" ref-type="fig">2A,&#x000a0;B</xref>). VmlR2-EQ<sub>2</sub> is bound in the ribosomal E site with closed NBDs and density corresponding to two bound NTP molecules, presumably ATP (Figure <xref rid="F2" ref-type="fig">2A</xref>&#x02013;<xref rid="F2" ref-type="fig">C</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6A,&#x000a0;B</xref>). The VmlR2 &#x003b1;-helical interdomain linker extends from the E site into the PTC, overlapping the canonical position of a P-site tRNA (Figure <xref rid="F2" ref-type="fig">2D,E</xref>). This results in a distorted tRNA occupying the P site, with the tRNA elbow contacting the VmlR2 NBD2, pulled towards the E site, and the acceptor stem highly distorted. Poor density for the P-tRNA acceptor stem indicates a high degree of flexibility in this region, and in particular the CCA-3&#x02032; end could not be modelled (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6C</xref>).</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>Cryo-EM structure of <italic toggle="yes">N. vireti</italic> VmlR2-EQ<sub>2</sub> bound to the 70S ribosome. (<bold>A</bold>) Overview of cryo-EM density containing the large ribosomal subunit (grey), VmlR2 (brown), and the small ribosomal subunit (yellow). (<bold>B</bold>) As for (A), except the large ribosomal subunit is shown as an outline only. A distorted P-tRNA is coloured cyan, and a substoichiometric A-tRNA is pink. (<bold>C</bold>) Isolated density and model of VmlR2 only. The model is coloured by domain, with ATPs coloured red. Non-sharpened maps are shown. (<bold>D</bold>) View of P- and A-tRNAs poised for peptidyl transfer in the PTC (pre-attack state, PDB ID 1VY4, (<xref rid="B113" ref-type="bibr">113</xref>)). The position of lincomycin is superimposed (PDB ID 8A5I, (<xref rid="B114" ref-type="bibr">114</xref>)). (<bold>E</bold>) Same view as D but showing the VmlR2 (brown) and <italic toggle="yes">B. subtilis</italic> VmlR (transparent, orange, PDB ID 6HA8, (<xref rid="B34" ref-type="bibr">34</xref>)) interdomain linkers. A dashed circle indicates the site of PLS<sub>A</sub> binding. Distorted P-tRNAs are shown in cyan, and a dashed line indicates the approximate path of the tRNA CCA-3&#x02032; end, which was not modelled. (<bold>F</bold>) Close view of the VmlR2 ARD reaching into the PTC. Ile261 is predicted to clash with superimposed lincomycin (PDB ID 8A5I). Van der Waals radii of the two closest atoms are shown as semi-transparent spheres, with a red line indicating a clash between them. (<bold>G</bold>) VmlR2 Y223 forms a stacking interaction with U2585. (<bold>H</bold>) View of PL2 forming part of the lincomycin binding site with 23S rRNA nucleotides shown in cyan (PDB ID 8A5I). (<bold>I</bold>) Same as H but with VmlR2 superimposed. 23S rRNA nucleotides from the VmlR2-bound structure are shown in grey. Models were aligned by 23S rRNA.</p></caption><graphic xlink:href="gkad193fig2" position="float"/></fig><p>As observed previously in ABCF samples prepared by <italic toggle="yes">ex vivo</italic> immunoprecipitation (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>), the density of the P-site tRNA was most consistent with an initiator fMet-tRNA (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6C</xref>), and density for the P-site codon was most consistent with AUG (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6D</xref>). An apparent Shine-Dalgarno&#x02013;anti-Shine-Dalgarno helix is positioned in the mRNA exit channel, close to, but not visibly contacting, the VmlR2 CTD (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6E</xref>). A sub-stoichiometric tRNA is present in the A site, as observed previously for the 70S-LsaA-EQ<sub>2</sub> complex from <italic toggle="yes">Enterococcus faecalis</italic>, and sub-classification revealed that the A-site tRNA can adopt multiple conformations (Figure <xref rid="F2" ref-type="fig">2B</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7</xref>). These observations imply that VmlR2-EQ<sub>2</sub> had bound to and stalled the 70S ribosome after translation initiation, but before the first translocation event, which is the same state stalled by PLS<sub>A</sub> and nucleoside antibiotics (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B96" ref-type="bibr">96</xref>).</p><p>As expected from the high degree of sequence homology, the structure of VmlR2 bound to the 70S ribosome is globally similar to <italic toggle="yes">B. subtilis</italic> VmlR bound to the 70S, with a root square mean deviation (RMSD) of 1.44 &#x000c5; between the two factors after least-squares fitting. In particular, the &#x003b1;-helices of the well-resolved interdomain linker, which travel through the path normally occupied by the P-tRNA to reach into the PTC, are highly structurally conserved (Figure <xref rid="F2" ref-type="fig">2D,&#x000a0;E</xref>). The ends of the &#x003b1;-helices and the ARD-loop linking them, diverge from the equivalent region in the <italic toggle="yes">B. subtilis</italic> VmlR (Figure <xref rid="F2" ref-type="fig">2E</xref>), as expected from the sequence alignment (Figure <xref rid="F1" ref-type="fig">1B</xref>). Compared to VmlR, the additional eight residues in the VmlR2 ARD are mostly oriented away from the PTC and drug binding site (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8A</xref>), similar to that observed for the ARDs of LsaA, VgaA<sub>LC</sub>&#x000a0;and VgaL, which are also extended compared to <italic toggle="yes">B. subtilis</italic> VmlR despite sharing a similar spectrum of antibiotic resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8B&#x02013;D</xref>) (<xref rid="B26" ref-type="bibr">26</xref>). Indeed, despite containing eight more amino acids than <italic toggle="yes">B. subtilis</italic> VmlR, the VmlR2 ARD reaches a similar site in the PTC as many other PLS<sub>A</sub>-specific ARE-ABCFs (Figure <xref rid="F2" ref-type="fig">2E</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref>). Residue Ile261 of VmlR2 overlaps with the binding site of PLS<sub>A</sub> and nucleoside antibiotics, similarly to Phe237 of <italic toggle="yes">B. subtilis</italic> VmlR except inserted approximately 1.4 &#x000c5; deeper into the PTC (Figure <xref rid="F2" ref-type="fig">2F</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9A&#x02013;H</xref>).</p><p>We next mutated selected residues of the ARD-loop of VmlR2 to alanine and assessed the ability of the resulting VmlR2 variants to mediate antibiotic resistance in a &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> background (Table <xref rid="tbl2" ref-type="table">2</xref>). As observed for other antibiotic-resistance ABCFs, mutating the only residue that overlaps with the PLS<sub>A</sub> binding site, in this case Ile261 to alanine, did not appreciably shift the antibiotic resistance spectrum of VmlR2 (Table <xref rid="tbl1" ref-type="table">1</xref>). However, due to the increased penetration of the VmlR2 ARD into the PTC, an alanine side chain at position 261 is also predicted to still overlap with the PLS<sub>A</sub> binding site (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9I&#x02013;K</xref>). Therefore, we next performed a more radical substitution and replaced Ile261 with glycine. The Ile261Gly substitution, which is predicted to remove overlap between VmlR2 and the drugs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9L&#x02013;N</xref>), compromised the activity of VmlR2 against retapamulin and virginiamycin M1 but not against lincomycin and iboxamycin (Table <xref rid="tbl1" ref-type="table">1</xref>). This antibiotic-specific loss of protective activity is reminiscent of the effect we have previously observed with the Phe237Val substitution in <italic toggle="yes">B. subtilis</italic> VmlR (<xref rid="B34" ref-type="bibr">34</xref>). We therefore conclude that while the Ile261 sidechain is not required for antibiotic resistance.</p><table-wrap position="float" id="tbl2"><label>Table 2.</label><caption><p>Effects of CplR and Erm functionality on resistance of <italic toggle="yes">C. difficile</italic> to nucleoside and PLS<sub>A</sub> antibiotics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="9" align="center" rowspan="1">MIC (&#x003bc;g/ml)</th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">C. difficile</italic> strain</th><th rowspan="1" colspan="1">
<italic toggle="yes">erm</italic>
</th><th rowspan="1" colspan="1">A201A</th><th rowspan="1" colspan="1">Hygromycin A</th><th rowspan="1" colspan="1">Retapamulin</th><th rowspan="1" colspan="1">Lincomycin</th><th rowspan="1" colspan="1">Clindamycin</th><th rowspan="1" colspan="1">Iboxamycin</th><th rowspan="1" colspan="1">Virginiamycin M1</th><th rowspan="1" colspan="1">Erythromycin</th><th rowspan="1" colspan="1">Florfenicol</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">R20291</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.0625</td><td rowspan="1" colspan="1">128</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630</td><td rowspan="1" colspan="1">
<italic toggle="yes">c-erm</italic>
</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.4</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">256</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">128</td><td rowspan="1" colspan="1">&#x0003e;256</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.8&#x02013;1.6</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.1</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">0.0156</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic>/pRFP185</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.2</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.03125</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic>/pRFP185</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">0.03125</td><td rowspan="1" colspan="1">0.03125</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic>/pRFP185-<italic toggle="yes">cplR</italic></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">1.6</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">&#x0003c;0.00781</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic> /pRFP185-<italic toggle="yes">cplR&#x00394;C</italic></td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">0.0625</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td></tr></tbody></table><table-wrap-foot><fn id="T2TFN1"><p>
<italic toggle="yes">C. difficile</italic> MIC testing was carried out in BHIS media, and growth inhibition was scored after 36&#x02013;48 h of anaerobic incubation at 37&#x000b0;C. Plasmid-harboring strains were cultured in BHIS media supplemented with 10 &#x003bc;g/ml thiamphenicol (to maintain the plasmids) and 500 ng/ml anhydrotetracycline (to induce the expression of ARE-ABCF proteins).</p></fn></table-wrap-foot></table-wrap><p>Mutation of other selected residues close to the drug-binding site resulted in a complex pattern of changes to antibiotic resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S10</xref>). Residues Arg259 and Gln260, positioned in the tip of the ARD, were insensitive to mutation to alanine despite making defined contacts with the 23S rRNA (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S10A,&#x000a0;B</xref>). By contrast, VmlR2 Y266 was required for resistance to tiamulin and virginiamycin M. This residue is positioned similarly to <italic toggle="yes">B. subtilis</italic> VmlR Y240 and VgaA<sub>LC</sub> Y223, with each residue stacking with 23S rRNA nucleotide U2585 (<italic toggle="yes">E. coli</italic> numbering; Figure <xref rid="F2" ref-type="fig">2G</xref>), and we previously found that a VgaA<sub>LC</sub> Y223A variant also displayed reduced resistance against PLS<sub>A</sub> antibiotics (<xref rid="B26" ref-type="bibr">26</xref>). The adjacent residue, E265, also had a drastic effect on antibiotic resistance when mutated to alanine. E265 is within hydrogen-bonding distance of 23S rRNA residues A2450 and A2451, which form part of a region we have previously termed PTC loop 2 (PL2, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S10C</xref>, (<xref rid="B26" ref-type="bibr">26</xref>)). Interactions between VmlR2 and the 23S rRNA in this region may serve to position the VmlR2 ARD in the PTC.</p><p>Finally, we have truncated the very tip of the ARD including the above-mentioned Arg259 and Gln260. The &#x00394;254&#x02013;261 (&#x00394;SASERRQI) VmlR2 variant (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8A</xref>) displayed (albeit diminished) protective activity against all of the antibiotics tested, i.e. retapamulin, virginiamycin M1, iboxamycin and lincomycin. This result further reinforces the idea that VmlR2 acts allosterically to protect the ribosome.</p><p>In summary, residues that interact with U2585 and A2450/A2451, located at the beginning of interdomain linker &#x003b1;2, appear to be important for PLS<sub>A</sub> resistance mediated by VmlR2, while by contrast, mutating the residue that physically overlaps with the PLS<sub>A</sub> binding site or other residues in the extended tip of the ARD does not affect antibiotic resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S10C,D</xref>). These observations are consistent with previous mutagenesis studies of ARE-ABCFs (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>). Previously, we proposed a model in which ARE-ABCFs confer antibiotic resistance by modulation of the antibiotic binding site (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>). Similar to <italic toggle="yes">B. subtilis</italic> VmlR, VmlR2 modulates the conformation of several 23S rRNA nucleotides that form the PLS<sub>A</sub> binding site. In particular, nucleotides around A2451, part of PL2, are displaced in the VmlR2-bound structure compared to the antibiotic-bound structures or a stalled elongating ribosome (Figure <xref rid="F2" ref-type="fig">2H,I</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S11</xref>). We therefore propose that binding of VmlR2 to a PLS<sub>A</sub>- or nucleoside-bound ribosome triggers a distortion of the antibiotic-binding site, in turn leading to dissociation of the antibiotic and ultimately allowing translation to resume after dissociation of the ARE-ABCF.</p></sec><sec id="SEC3-4"><title>CplR contributes to intrinsic PLS<sub>A</sub> resistance in Clostridia</title><p>Next, we characterised the resistance mediated by <italic toggle="yes">C. difficile, C. perfringens</italic> and <italic toggle="yes">C. sporogenes</italic> CplR in the native bacterial hosts.</p><p>In our <italic toggle="yes">C. difficile</italic> antibiotic sensitivity experiments we used two strains: the <italic toggle="yes">erm-</italic> R20291 and the <italic toggle="yes">erm</italic>&#x000a0;+&#x000a0;630. R20291 is an epidemic hypervirulent strain that belongs to PCR-ribotype 027 (<xref rid="B97" ref-type="bibr">97</xref>). The MIC values determined with this strain are directly comparable with <italic toggle="yes">erm</italic><italic toggle="yes">-</italic> ATCC 700057 MICs reported by Mitcheltree and colleagues in the original iboxamycin study (<xref rid="B12" ref-type="bibr">12</xref>). Despite encoding a genomic copy of CplR, both R20291 and ATCC 700057 are sensitive to iboxamycin (MIC of 0.0625 &#x003bc;g/ml for R20291, MIC of 0.25 &#x003bc;g/ml for ATCC 700057 (<xref rid="B12" ref-type="bibr">12</xref>)) (Table <xref rid="tbl2" ref-type="table">2</xref>).</p><p>The <italic toggle="yes">C. difficile</italic> 630 wild-type reference strain is a clinical isolate that over the years gained popularity with the research community (<xref rid="B98" ref-type="bibr">98</xref>). The prophage region of the mobilizable, non-conjugative transposon Tn<italic toggle="yes">5398</italic> present in the genome of <italic toggle="yes">C. difficile</italic> 630 encodes a tandem expression cassette for two identical copies of the <italic toggle="yes">ermB</italic> gene for rRNA adenine N-6-methyltransferase (<xref rid="B55" ref-type="bibr">55</xref>). This ubiquitous antibiotic resistance determinant confers resistance to macrolides as well as lincomycin and clindamycin (<xref rid="B99" ref-type="bibr">99</xref>,<xref rid="B100" ref-type="bibr">100</xref>). Compared to wild-type 630, the &#x00394;<italic toggle="yes">erm</italic> 630 <italic toggle="yes">C. difficile</italic> is more sensitive to pleuromutilin retapamulin (MIC for of 0.4 &#x003bc;g/ml vs 1.6 &#x003bc;g/ml) as well as lincosamides (MIC for lincomycin of 16 &#x003bc;g/ml vs&#x000a0;&#x0003e;&#x000a0;256 &#x003bc;g/ml, MIC for clindamycin of 16 &#x003bc;g/ml versus 256 &#x003bc;g/ml and MIC for iboxamycin of 0.25 &#x003bc;g/ml vs 16 &#x003bc;g/ml) (Table <xref rid="tbl2" ref-type="table">2</xref>). Since in <italic toggle="yes">B. subtilis</italic> VmlR synergises with Cfr to grant high levels of resistance (<xref rid="B48" ref-type="bibr">48</xref>), we next tested the effects of CplR loss in &#x00394;<italic toggle="yes">erm</italic> 630 <italic toggle="yes">C. difficile</italic>. The strain is further sensitised to lincosamides (MIC for lincomycin, clindamycin and iboxamycin of 0.1, 0.5 and&#x000a0;&#x0003c;0.125 &#x003bc;g/ml, respectively) as well as virginiamycin M1 (MIC of 16 &#x003bc;g/ml) but not florfenicol or hygromycin A. The effect of CplR expression on nucleoside resistance is minor: a mere 2-fold increase in sensitivity to A201A, and no effect on sensitivity to hygromycin A (Table <xref rid="tbl2" ref-type="table">2</xref>, compare 630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic> to 630&#x00394;<italic toggle="yes">erm</italic> as well as 630&#x00394;<italic toggle="yes">erm</italic> &#x00394;<italic toggle="yes">cplR</italic>/pRFP185 to 630&#x00394;<italic toggle="yes">erm</italic> &#x00394;c<italic toggle="yes">plR</italic>/pRFP185-<italic toggle="yes">cplR</italic>). Our results establish that the synergetic action of Erm and CplR is responsible for the ability of wild-type <italic toggle="yes">C. difficile</italic> 630 to resist PLS<sub>A</sub> antibiotics, including iboxamycin (MIC of 16 &#x003bc;g/ml).</p><p>Next, we tested the effects of CplR loss on antibiotic sensitivity of <italic toggle="yes">C. perfringens</italic> (Table <xref rid="tbl3" ref-type="table">3</xref>) and <italic toggle="yes">C. sporogenes</italic> (Table <xref rid="tbl4" ref-type="table">4</xref>). Compared to wild-type HN13 <italic toggle="yes">C. perfringens</italic>, the isogenic strain harbouring a markerless disruption of <italic toggle="yes">cplR</italic> is sensitised to the pleuromutilin retapamulin (32-fold increased sensitivity, MIC of 0.8 vs 0.025 &#x003bc;g/ml), lincosamides (MICs dropping 8- (lincomycin), 2- (iboxamycin) or &#x0003e;32-fold (clindamycin)), as well as virginiamycin M1 (a 2-fold MIC drop). Conversely, ectopic overexpression of CplR<italic toggle="yes"><sup>Cp</sup></italic> from the pJIR 750 vector in the &#x00394;<italic toggle="yes">cplR</italic> background drastically increased the MICs against retapamulin, lincomycin, clindamycin and iboxamycin, exceeding that of the wild-type HN13 <italic toggle="yes">C. perfringens</italic> by 8-fold (Table <xref rid="tbl3" ref-type="table">3</xref>).</p><table-wrap position="float" id="tbl3"><label>Table 3.</label><caption><p>Effects of CplR functionality on <italic toggle="yes">C. perfringens</italic> resistance to PLS<sub>A</sub> and macrolide antibiotics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="8" align="center" rowspan="1">MIC (&#x003bc;g/ml)</th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">C. perfringens</italic> strain</th><th rowspan="1" colspan="1">
<italic toggle="yes">erm</italic>
</th><th rowspan="1" colspan="1">A201A</th><th rowspan="1" colspan="1">Hygromycin A</th><th rowspan="1" colspan="1">Retapamulin</th><th rowspan="1" colspan="1">Lincomycin</th><th rowspan="1" colspan="1">Clindamycin</th><th rowspan="1" colspan="1">Iboxamycin</th><th rowspan="1" colspan="1">Virginiamycin M1</th><th rowspan="1" colspan="1">Erythromycin</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">wt/pJIR750</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.8</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.0156</td><td rowspan="1" colspan="1">3.2</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">cplR</italic>/pJIR750</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">&#x0003c;0.0625</td><td rowspan="1" colspan="1">0.0078</td><td rowspan="1" colspan="1">1.6</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">&#x00394;<italic toggle="yes">cplR</italic>/pJIR750-cplR</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">12.8</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">3.2</td><td rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="T3TFN1"><p>The MIC test for <italic toggle="yes">C. perfringens</italic> was carried out in GAM media and the growth inhibition was scored after 24 h of anaerobic incubation at 37&#x000b0;C. In the case of plasmid-harboring strains GAM media was attentionally supplemented with 10 &#x003bc;g/ml chloramphenicol to maintain the plasmids. Expression of the CplR ARE-ABCF was driven by the native promotor.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl4"><label>Table 4.</label><caption><p>Effects of CplR functionality on <italic toggle="yes">C. sporogenes</italic> resistance to nucleoside, PLS<sub>A</sub> and macrolide antibiotics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="8" align="center" rowspan="1">MIC (&#x003bc;g/ml)</th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">C. sporogenes</italic> strain</th><th rowspan="1" colspan="1">
<italic toggle="yes">erm</italic>
</th><th rowspan="1" colspan="1">A201A</th><th rowspan="1" colspan="1">Hygromycin A</th><th rowspan="1" colspan="1">Retapamulin</th><th rowspan="1" colspan="1">Lincomycin</th><th rowspan="1" colspan="1">Clindamycin</th><th rowspan="1" colspan="1">Iboxamycin</th><th rowspan="1" colspan="1">Chloramphenicol</th><th rowspan="1" colspan="1">Erythromycin</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">JCM1416 wt</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">25.6</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.5</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">cplR</italic>::<italic toggle="yes">intron</italic>-<italic toggle="yes">ermB</italic></td><td rowspan="1" colspan="1">
<italic toggle="yes">c</italic>-<italic toggle="yes">ermB</italic></td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">256</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.03125</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x0003e;256</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">sigD</italic>::<italic toggle="yes">intron</italic>-<italic toggle="yes">ermB</italic></td><td rowspan="1" colspan="1">
<italic toggle="yes">c</italic>-<italic toggle="yes">ermB</italic></td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">25.6</td><td rowspan="1" colspan="1">256</td><td rowspan="1" colspan="1">128</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#x0003e;256</td></tr></tbody></table><table-wrap-foot><fn id="T4TFN1"><p>The MIC test for <italic toggle="yes">C. sporogenes</italic> was carried out in GAM media, and the growth inhibition was scored after 24 h of anaerobic incubation at 37&#x000b0;C.</p></fn></table-wrap-foot></table-wrap><p>To test the role of CplR in antibiotic resistance of <italic toggle="yes">C. sporogenes</italic>, we constructed a strain in which the <italic toggle="yes">cplR<sup>Cs</sup></italic> gene is disrupted by the insertion of the <italic toggle="yes">intron</italic>-<italic toggle="yes">ermB</italic> resistance marker (Table <xref rid="tbl4" ref-type="table">4</xref>). To deconvolute the effect of the introduced <italic toggle="yes">ermB</italic> gene on antibiotic resistance from that of <italic toggle="yes">cplR</italic><sup>Cs</sup> disruption, we also constructed a strain in which the <italic toggle="yes">intron</italic>-<italic toggle="yes">ermB</italic> marker is introduced into the <italic toggle="yes">sigD</italic> locus. Compared to the isogenic wild type, the <italic toggle="yes">cplR</italic>::<italic toggle="yes">intron-ermB</italic> strain is more sensitive to retapamulin (MICs of 0.025 &#x003bc;g/ml versus 25.6 &#x003bc;g/ml, Table <xref rid="tbl4" ref-type="table">4</xref>) suggesting that CplR mediates resistance to pleuromutilins. As expected, the introduction of the ErmB marker the <italic toggle="yes">cplR</italic>::<italic toggle="yes">intron-ermB</italic> strain displays higher resistance to lincomycin than the isogenic wild type (MIC for lincomycin of 256 &#x003bc;g/ml versus 32 &#x003bc;g/ml, Table <xref rid="tbl4" ref-type="table">4</xref>). At the same time, the <italic toggle="yes">cplR</italic>::<italic toggle="yes">intron-ermB</italic> strain is more sensitive to iboxamycin (MICs of 0.031 &#x003bc;g/ml versus 0.125 &#x003bc;g/ml), consistent with the role of CplR in lincosamide resistance. The antibiotic resistance function of ClpR&#x000a0;is further supported by the clindamycin and iboxamycin MIC of the <italic toggle="yes">cplR</italic>-disrupted mutant being lower than that of the <italic toggle="yes">sigD</italic> mutant (compare <italic toggle="yes">cplR</italic>:<italic toggle="yes">intron-ermB</italic> to <italic toggle="yes">sigD</italic>::<italic toggle="yes">intron-ermB</italic>: clindamycin MICs of 8 &#x003bc;g/ml vs 128 &#x003bc;g/ml, iboxamycin MICs of 0.031 &#x003bc;g/ml versus 16 &#x003bc;g/ml) (Table <xref rid="tbl4" ref-type="table">4</xref>). Finally, the effects on nucleoside antibiotic sensitivity are minor (2-fold increased sensitivity to hygromycin B, and no effect on sensitivity to A201A).</p><p>Taken together, our results establish ARE1 CplR as a clostridial&#x000a0;genome-encoded PLS<sub>A</sub> resistance determinant and suggest that high PLS<sub>A</sub> resistance levels of <italic toggle="yes">C. difficile</italic> 630 are mediated through a combined action of direct ribosome protection by CplR and 23S rRNA modification by the ErmB methyltransferase.</p></sec><sec id="SEC3-5"><title>An antibiotic challenge induces the accumulation of <italic toggle="yes">C. difficile</italic><italic toggle="yes">cplR</italic> full-length mRNA, and expression is re-repressed once bacterial growth is restored</title><p>Expression of ARE-ABCFs is typically induced upon a sub-MIC antibiotic challenge through a de-repression mechanism, with the full-length mRNA levels being kept low in the absence of the cognate antibiotic due to premature transcription termination in the absence of ribosomal stalling on a regulatory uORF (<xref rid="B27" ref-type="bibr">27&#x02013;32</xref>).</p><p>Genome-wide mapping of transcriptional start sites (TSSs; identified using dRNA-seq) and termination sites (TTSs; identified using RNAtag-seq) in <italic toggle="yes">C. difficile</italic> 630 (<xref rid="B54" ref-type="bibr">54</xref>) revealed that i) the <italic toggle="yes">cplR</italic> ORF preceded by a 212 nucleotide-long 5&#x02032;&#x000a0;upstream region (CDIF630nc_084), and that ii) as expected for an ARE-ABCF, under non-inducing conditions, the transcript prematurely terminates at start codon of the <italic toggle="yes">cplR</italic> ORF (CDIF630_02847) (Figure <xref rid="F3" ref-type="fig">3A</xref>). Since antibiotic-induced ribosomal stalling by a regulatory uORF is a common regulatory strategy employed for inducible control of ARE-ABCF expression (<xref rid="B27" ref-type="bibr">27&#x02013;32</xref>), we have mounted an <italic toggle="yes">in silico</italic> search for regulatory ORFs of CplR and close relatives using our bioinformatic tool for uORF detection, uORF4u (<xref rid="B61" ref-type="bibr">61</xref>). Sequence conservation analysis reveals that the uORF of Clostridial CplR has a consensus of MR[I/M], with <italic toggle="yes">C. difficile cplR</italic> uORF specifically encoding Met-Arg-Ile (Figure <xref rid="F3" ref-type="fig">3B,&#x000a0;C</xref>). The consensus is different from the uORF4u-computed uORF for VmlR (MIN, Figure <xref rid="F3" ref-type="fig">3C</xref>), VmlR2 (MK[L/Q], Figure <xref rid="F3" ref-type="fig">3D</xref>) and LsaA (MAGN, Figure <xref rid="F3" ref-type="fig">3F</xref>), despite the four ARE-ABCFs having similar resistance spectra. The identified short uORFs are likely to be stalled by PLS<sub>A</sub> and nucleoside antibiotics, which inhibit translation after initiation with little context-specificity (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B96" ref-type="bibr">96</xref>). We could not identify an adequate number of sufficiently closely related homologues for the tool to be able to predict any conserved uORFs for Ard1.</p><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Nucleotide sequence and predicted secondary structures of the 5&#x02032; leader region of <italic toggle="yes">cplR</italic> mRNA in induced and repressed conformations. (<bold>A</bold>) dRNA-seq (sampled in late exponential or stationary phase) and RNAtag-seq reads for annotation of transcriptional start sites (TSSs) and termination sites (TTSs), respectively, mapped to 5&#x02032;&#x000a0;upstream region (CDIF630nc_084) preceding the <italic toggle="yes">cplR</italic> ORF (CDIF630_02847) (<xref rid="B54" ref-type="bibr">54</xref>). (<bold>B</bold>) Alignments of 5&#x02032;&#x000a0;upstream regions elements in Clostridial CplRs and <italic toggle="yes">L. monocytogenes</italic> Lmo0919/VgaL focused on the uORF and anti-Shine-Dalgarno (anti-SD) elements. (C&#x02013;F) Consensus sequences for (<bold>C</bold>) CplR, (<bold>D</bold>) VmlR, (<bold>E</bold>) VmlR2 and (<bold>F</bold>) LsaA uORF elements. The full uORF peptide alignments are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 3</xref>. (<bold>G</bold> and <bold>H</bold>) Predicted secondary structure of <italic toggle="yes">cplR</italic> mRNA 5&#x02032; leader region in repressed (G, in the absence of antibiotic-induced ribosomal stalling on the uORF(MRI)) and induced (H, in the presence of ribosomal stalling). Substitutions that were used for experimental probing the key functional elements are shown in red.</p></caption><graphic xlink:href="gkad193fig3" position="float"/></fig><p>We predicted secondary structures of the 5&#x02032;&#x000a0;<italic toggle="yes">cplR</italic> leader region in induced (i.e. full-length mRNA with 70S ribosome stalled on the uORF in the presence of antibiotics) and repressed (i.e. prematurely terminated mRNA generated in the absence of antibiotics) conformations using RNAfold (<xref rid="B66" ref-type="bibr">66</xref>) and Mfold (<xref rid="B101" ref-type="bibr">101</xref>). In the repressed conformation the 5&#x02032;&#x000a0;<italic toggle="yes">cplR</italic> leader region is predicted to form two stable stem loop structures (Figure <xref rid="F3" ref-type="fig">3G</xref>). The 5&#x02032;&#x000a0;hairpin sequesters the putative regulatory uORF(MRI). The 3&#x02032;&#x000a0;terminator hairpin is followed by a single-stranded polyU stretch, thus constituting a canonical signal for efficient intrinsic termination in bacteria (<xref rid="B102" ref-type="bibr">102&#x02013;105</xref>). Importantly, the stem loop of the terminator hairpin sequesters the Shine-Dalgarno element positioned to drive the expression of the <italic toggle="yes">cplR</italic> ORF, potentially mediating the suppression of the <italic toggle="yes">cplR</italic> expression from full-length mRNA transcripts that fail to terminate prematurely. In repressed conformation the terminator hairpin is not formed, with an anti-terminator stem loop formed instead which allows transcription of full-length mRNA (Figure <xref rid="F3" ref-type="fig">3H</xref>). Furthermore, the Shine-Dalgarno that drives the <italic toggle="yes">cplR</italic> expression is readily accessible for initiating ribosomes (Figure <xref rid="F3" ref-type="fig">3D</xref>).</p><p>To test antibiotic-inducible expression of <italic toggle="yes">C. difficile cplR</italic>, we cultured 630&#x00394;<italic toggle="yes">ermR C. difficile</italic> in the presence of increasing sub-MIC concentrations of retapamulin (2&#x02013;200 ng/ml; MIC of 800&#x02013;1600 ng/ml) and lincomycin (0.02&#x02013;2.0 &#x003bc;g/ml; MIC of 32 &#x003bc;g/ml) and assessed the levels of <italic toggle="yes">cplR</italic> mRNA by RT-PCR using two primer pairs: one amplifying 5&#x02032; leader region and the other targeting the ORF (Figure <xref rid="F4" ref-type="fig">4A</xref>). As expected, the level of <italic toggle="yes">cplR</italic> mRNA was increased in a dose-dependent manner for both retapamulin and lincomycin treatment, with the RT-PCR signal for both mRNA regions increasing upon antibiotic challenge (Figure <xref rid="F4" ref-type="fig">4B</xref>).</p><fig position="float" id="F4"><label>Figure 4.</label><caption><p>
<italic toggle="yes">cplR</italic> expression is de-repressed in <italic toggle="yes">C. difficile</italic> upon retapamulin or lincomycin challenge and re-repressed once the bacterial growth recovers. (<bold>A</bold>) Experimental setup used for <italic toggle="yes">cplR</italic> mRNA detection by RT-PCR using primers specific for <italic toggle="yes">cplR</italic> 5&#x02032; leader region, <italic toggle="yes">cplR</italic> ORF and <italic toggle="yes">fdxA</italic> ORF. (<bold>B</bold>) <italic toggle="yes">cplR</italic> mRNA accumulates in a dose-dependent manner in response to the addition of increasing concentrations of either retapamulin or lincomycin. The antibiotics were added to logarithmic phase <italic toggle="yes">C. difficile</italic> 630 &#x00394;<italic toggle="yes">ermR</italic> cultures of and total RNA collected 2 h after the antibiotic challenge. 23S and 16S rRNA were used as loading controls. (<bold>C</bold>) Kinetics of <italic toggle="yes">cplR</italic> mRNA accumulation in response to a sub-MIC challenge with retapamulin (200 ng/ml) or lincomycin (2 &#x003bc;g/ml). (<italic toggle="yes">Left</italic>) <italic toggle="yes">cplR</italic> 5&#x02032; leader region, <italic toggle="yes">cplR</italic> ORF and <italic toggle="yes">fdxA</italic> ORF were probed by RT-PCR amplification. (<italic toggle="yes">Right</italic>) Growth kinetics of <italic toggle="yes">C. difficile</italic> in the absence or presence of sub-MIC concentrations of retapamulin (200 ng/ml) or lincomycin (2 &#x003bc;g/ml). The time point of antibiotic addition is set as zero on the time axis.</p></caption><graphic xlink:href="gkad193fig4" position="float"/></fig><p>Next, we investigated the time-course of <italic toggle="yes">cplR</italic> expression upon antibiotic challenge. We hypothesised that when the inhibitory effect of the antibiotic on translation is relieved by the ARE-ABCF, the expression of the factor should subside as the antibiotic-induced ribosomal stalling that drives the expression is abolished. To test this hypothesis, we contrasted the RT-PCR data with bacterial growth kinetics. The <italic toggle="yes">cplR</italic> expression quickly responded to the antibiotic challenge, peaking within 30 min after the addition of antibiotics (Figure <xref rid="F4" ref-type="fig">4C</xref>, <italic toggle="yes">left</italic>). Importantly, while the retapamulin-induced growth inhibition was severe and persisted for the whole duration of the experiment, the lincomycin-induced growth inhibition is much milder and at the later time points the growth kinetics are similar to that one the untreated control (Figure <xref rid="F4" ref-type="fig">4C</xref>, <italic toggle="yes">right</italic>). Consistent with the prediction, while in the presence of 200 ng/ml retapamulin the maximal levels of <italic toggle="yes">cplR</italic> mRNA are maintained throughout the 6 h of the RT-PCR time course, but the <italic toggle="yes">cplR</italic> mRNA levels gradually decreased as bacterial growth &#x02013; and, by inference, protein synthesis &#x02013; has recovered from the lincomycin challenge (Figure <xref rid="F4" ref-type="fig">4C</xref>, <italic toggle="yes">left</italic>).</p><p>Collectively, our results suggest that (i) inhibition of translation by retapamulin or lincomycin induces accumulation of <italic toggle="yes">cplR</italic> mRNA and (ii) induction of <italic toggle="yes">cplR</italic> mRNA is abrogated once expression of the factor overcomes the drug-induced translation inhibition.</p></sec><sec id="SEC3-6"><title>The 5&#x02032; leader region of <italic toggle="yes">cplR</italic> controls the induction of ABCF expression upon an antibiotic challenge</title><p>To test the role of the predicted 5&#x02032;&#x000a0;<italic toggle="yes">cplR</italic> leader region elements in antibiotic-induced expression of <italic toggle="yes">cplR</italic> in <italic toggle="yes">C. difficile</italic> we used a series of reporter constructs in which the expression of the mCherry red fluorescent protein was driven by the native <italic toggle="yes">cplR</italic> promoter (P<italic toggle="yes"><sub>cplR</sub></italic>) with either wild-type or mutated 5&#x02032;&#x000a0;leader variants (Figure <xref rid="F5" ref-type="fig">5A</xref>). We used (i) RT-PCR to assess the effects of 5&#x02032;&#x000a0;leader mutations and/or antibiotic challenge that act on the level of transcription and (ii) mCherry fluorescence measurements to assess the compound effects that act both on transcriptional and translational levels simultaneously.</p><fig position="float" id="F5"><label>Figure 5.</label><caption><p>The ribosomal stalling on the uORF but not the premature RNAP termination is essential for induction of <italic toggle="yes">cplR</italic> in response to antibiotic challenge. (<bold>A</bold>) Experimental setup used for mutational probing of the <italic toggle="yes">cplR</italic> 5&#x02032; leader region. Fluorescent reporters relied on mCherry expression driven by the <italic toggle="yes">cplR</italic> promotor (P<italic toggle="yes"><sub>CplR</sub></italic>) using wither (i) wild-type <italic toggle="yes">cplR</italic> 5&#x02032; leader, (ii) <italic toggle="yes">fdxA</italic> 5&#x02032; leader (5&#x02032; leader<italic toggle="yes"><sub>fdxA</sub></italic>), (iii&#x02013;v) <italic toggle="yes">cplR</italic> 5&#x02032; leader with substitutions in the uORF start codon (mut<sup>uORF</sup>), the intrinsic terminator stem (mut<sup>termSL</sup>) or the polyU track downstream of the intrinsic terminator stem loop (mut<sup>polyU</sup>). Locations of the substitutions on the mRNA secondary structure are presented on Figure <xref rid="F3" ref-type="fig">3CD</xref>. (<bold>B</bold>) Accumulation <italic toggle="yes">mCherry</italic> mRNA variants with different <italic toggle="yes">cplR</italic> 5&#x02032; leaders in response to a sub-MIC challenge with lincomycin (2 &#x003bc;g/ml). The antibiotics were added to the logarithmic phase of <italic toggle="yes">C. difficile</italic> 630 &#x00394;<italic toggle="yes">ermR</italic> culture and total RNA was collected 30 mins after the antibiotic challenge. <italic toggle="yes">mCherry</italic> ORF and <italic toggle="yes">fdx</italic> ORF were probed by RT-PCR amplification. 23S rRNA was used as loading control. (<bold>C</bold> and <bold>D</bold>) Mutational probing of the <italic toggle="yes">cplR</italic> 5&#x02032; leader. Expression of mCherry driven by is 5&#x02032; leader<italic toggle="yes"><sub>fdxA</sub></italic> (P<italic toggle="yes"><sub>fdx</sub></italic>-<italic toggle="yes">mCherry</italic>) is insensitive to sub-MIC challenge with retapamulin (C) or lincomycin (D). Wild-type P<italic toggle="yes"><sub>cplR</sub></italic>-<italic toggle="yes">mCherry</italic> reporter is induced by both retapamulin (C) and lincomycin (D), though the signal is much lower than in the case of P<italic toggle="yes"><sub>fdx</sub></italic>-<italic toggle="yes">mCherry</italic>. The mut<sup>termSL</sup> reporter is constitutively induced and is insensitive to addition of either retapamulin (C) or lincomycin (D). The mut<sup>polyU</sup> reporter is repressed in the absence of antibiotics and is induced by the retapamulin challenge (C). To calculate the relative promoter activity, relative fluorescence intensity normalised by O.D.<sub>600</sub> was further normalised by the signal from the constitutive P<italic toggle="yes"><sub>fdx</sub>-mCherry</italic> reporter.</p></caption><graphic xlink:href="gkad193fig5" position="float"/></fig><p>When P<italic toggle="yes"><sub>cplR</sub></italic> is used to drive the expression of <italic toggle="yes">mCherry</italic> preceded by wild-type <italic toggle="yes">cplR</italic> 5&#x02032;&#x000a0;leader, while virtually no RT-PCR or fluorescence signal is detectable in the absence of antibiotics, whereas addition of either retapamulin (at 0.2 &#x003bc;g/&#x003bc;l) or lincomycin (at 2 &#x003bc;g/ml) results in strong induction of the reporter (Figure <xref rid="F5" ref-type="fig">5B</xref>,&#x000a0;C, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S12</xref>). Conversely, when the 5&#x02032;&#x000a0;leader region is replaced with that of constitutively and strongly expressed ferredoxin gene (<italic toggle="yes">fdx</italic>) (<xref rid="B106" ref-type="bibr">106</xref>), both the RT-PCR (Figure <xref rid="F5" ref-type="fig">5B</xref>) and fluorescence (Figure <xref rid="F5" ref-type="fig">5C,&#x000a0;D</xref>) signal drastically increased and became insensitive to the antibiotic challenge. Taken together, these results suggest that our mCherry-based reporter strategy faithfully replicates the regulatory mechanisms that natively control the expression of <italic toggle="yes">cplR</italic>.</p><p>After establishing the validity of the assay, we next introduced point mutations in the <italic toggle="yes">cplR</italic> 5&#x02032; leader probing (i) the regulatory uORF (AUG to AUC substitution of the initiation codon; mut<sup>uORF</sup>), (ii) the terminator stem loop that sequesters the <italic toggle="yes">cplR</italic> main ORF Shine-Dalgarno motif (triple C-to-G substitution disrupting the helix; mut<sup>termSL</sup>) and, finally, (iii) the terminator polyU tract (triple U-to-A substitution; mut<sup>polyU</sup>) (Figures <xref rid="F3" ref-type="fig">3G</xref>,&#x000a0;H and 5A).</p><p>The mut<sup>uORF</sup> fluorescent reporter is inactive both in the presence and the absence of either retapamulin (Figure <xref rid="F5" ref-type="fig">5C</xref>) or lincomycin (Figure <xref rid="F5" ref-type="fig">5D</xref>), which is consistent with translation of the uORF being essential for the induction of <italic toggle="yes">cplR</italic>. The mut<sup>termSL</sup> reporter in which premature transcription termination is ablated and the Shine-Dalgarno (SD) element that drives expression of <italic toggle="yes">cplR</italic> is made directly accessible for translation initiation is (i) constitutively active and non-responsive to addition of antibiotics, and (ii) the fluorescent signal is &#x0003e;10-fold higher than that of the fully induced wild-type 5&#x02032;&#x000a0;leader reporter construct (Figure <xref rid="F5" ref-type="fig">5C</xref>, <xref rid="F5" ref-type="fig">D</xref>). By contrast, the expression of mCherry from the mut<sup>polyU</sup> reporter is (i) tightly regulated by antibiotics, with only very weak signal detectable in the absence of retapamulin, (ii) in the presence of retapamulin, the fluorescent signal was about twice (2.3-fold) as strong as that in the case of the wild-type reporter (Figure <xref rid="F5" ref-type="fig">5C</xref>). In the case of the mut<sup>polyU</sup> reporter the full-length mRNA is expected to be constitutively produced (just as in the case of mut<sup>termSL</sup>). Our RT-PCR experiments directly support this prediction: in good agreement with consistent production of the mut<sup>polyU</sup> reporter mRNA, the maximum induced signal is higher for the mut<sup>polyU</sup> reporter than for the wild-type reporter (Figure <xref rid="F5" ref-type="fig">5B</xref>). At the same time, the <italic toggle="yes">cplR</italic> SD element is expected&#x02014;just as in the wild-type reporter&#x02014;to be accessible only upon ribosomal stalling on the uORF, and, evidently, translational attenuation is sufficient to ensure the suppression of <italic toggle="yes">cplR</italic> expression in the absence of antibiotic.</p><p>Collectively, our results establish that translational attenuation and transcriptional attenuation synergise to control the inducible expression of CplR in <italic toggle="yes">C. difficile</italic>.</p></sec></sec><sec sec-type="discussion" id="SEC4"><title>DISCUSSION</title><p>We have experimentally characterised five genome-encoded ARE-ABCF proteins that are implicated in the intrinsic antibiotic resistance of <italic toggle="yes">S. capreolus</italic> (AAF1 Ard1), <italic toggle="yes">N. vireti</italic> (ARE2 VmlR2), and Clostridia <italic toggle="yes">C. difficile, C. perfringens</italic> and <italic toggle="yes">C. sporogenes</italic> (ARE1 CplR). As we show here, the &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> strain is a convenient surrogate host for uncovering the resistance spectra of different ARE-ABCFs. Thus, antibiotic sensitivity assays using heterologous expression in &#x00394;<italic toggle="yes">vmlR B. subtilis</italic> could be used to study other chromosomal ABCFs, guided by bioinformatic surveys.</p><p>Our cryo-EM reconstruction of the <italic toggle="yes">N. vireti</italic> VmlR2-70S complex is broadly similar to structures of other ARE-ABCFs with specificity for PLS<sub>A</sub> antibiotics. The ARD of these elements is counter-intuitively both essential for resistance and poorly conserved at the sequence level, exemplified by the eight-amino-acid insertion in the VmlR2 ARD compared to the <italic toggle="yes">B. subtilis</italic> VmlR ARD, despite the similar antibiotic resistance profiles of both these ARE-ABCFs (Figure <xref rid="F1" ref-type="fig">1B</xref>, Table <xref rid="tbl1" ref-type="table">1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref>). We observe the extended VmlR2 ARD to be oriented mostly away from the PTC and towards the P-tRNA, reminiscent of the ARDs from more distantly-related PLS<sub>A</sub>-specific ARE-ABCFs such as LsaA, VgaA<sub>LC</sub>&#x000a0;and VgaL (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref>). Thus, ARDs from PLS<sub>A</sub>-specific ARE-ABCFs can accommodate addition or deletion of amino acids while only modestly modulating their position with respect to the PTC. To date, all ribosome-bound ARE-ABCF structures have shown either a modest overlap between the factor and the antibiotic binding site, or no overlap at all&#x02014;a pattern which holds for ARE-ABCFs specific for both PLS<sub>A</sub>s as well as macrolide, ketolide, and streptogramin Bs (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B43" ref-type="bibr">43</xref>). This pattern is challenged by our results expanding the specificity of VmlR and VmlR2 to the nucleoside antibiotics A201A and Hygromycin A (Table <xref rid="tbl1" ref-type="table">1</xref>), as each of these antibiotics occupy the PLS<sub>A</sub> binding site but additionally extend towards the A site. Modelled overlaps between VmlR and these antibiotics are extensive (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9</xref>). However, consistent with previous ARE-ABCF structures, an overlap between the ARE-ABCF and the antibiotic is not strictly required for resistance, as mutants predicted to abrogate the modelled overlap do not abolish activity (Table <xref rid="tbl1" ref-type="table">1</xref>) (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B41" ref-type="bibr">41</xref>). We note that VmlR2 induces distortions in the PTC nucleotides that would disrupt the antibiotic binding site, especially in the region around A2451, which we term PTC loop 2. Such a distortion is common to other PLS<sub>A</sub> ARE-ABCFs (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>The most clinically important aspect of this work is the detailed study of the Clostridial ARE1 CplR. The Gram-positive anaerobic spore-forming bacterium <italic toggle="yes">C. difficile</italic> is a causative agent of nosocomial and chronic infections as well as healthcare-associated diarrhoea (<xref rid="B107" ref-type="bibr">107</xref>). Disruption of the protective gut microbiota by broad-spectrum antibiotics allows for efficient proliferation of antibiotic-resistant <italic toggle="yes">C. difficile</italic> in the gut, thus triggering <italic toggle="yes">C. difficile</italic> infection, CDI (<xref rid="B108" ref-type="bibr">108</xref>). <italic toggle="yes">C. difficile</italic> has high levels of antibiotic resistance, and treatment with lincosamides such as clindamycin has long been recognised as a risk factor for development of CDI, especially in the case of <italic toggle="yes">erm</italic>&#x000a0;+&#x000a0;strains (<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B56" ref-type="bibr">56&#x02013;59</xref>). As we show here, (i) similarly to <italic toggle="yes">L. monocytogenes</italic> ARE-ABCF VgaL and 23S ribosomal RNA methyltransferase Cfr (<xref rid="B48" ref-type="bibr">48</xref>), <italic toggle="yes">C. difficile</italic> CplR synergises with the 23S rRNA methyltransferase Erm to grant high levels of PLS<sub>A</sub> resistance, and, (ii) analogously to other experimentally studied ARE-ABCFs, induction of CplR is controlled by ribosomal stalling on a regulatory uORF. These results warrant a systematic exploration for co-occurrence of ARE-ABCFs and 23S rRNA methyltransferase antibiotic resistance determinants, with a special focus on the cases of their co-localisation in one operon on a mobile element (as is observed for LsaA and Cfr (<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B50" ref-type="bibr">50</xref>)). We demonstrate the utility of our bioinformatic tool uORF4u (<xref rid="B61" ref-type="bibr">61</xref>) for identification of regulatory uORFs and their consensus sequences. The induction of ARE-ABCFs relies on antibiotic-induced ribosomal stalling on regulatory uORFs (<xref rid="B27" ref-type="bibr">27&#x02013;32</xref>), and for elongation inhibitors such as macrolides, phenicols and oxazolidinones, antibiotic-induced ribosomal stalling is context-specific (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B109" ref-type="bibr">109&#x02013;112</xref>). A dedicated follow-up investigation of the relationship between uORF consensuses and ARE-ABCF resistance and antibiotic inducibility spectrum is warranted. The specific sequence conservation of the uORF could point towards as-yet-uncharacterized patterns of sequence-specific antibiotic-mediated ribosomal stalling that are used by the cell to trigger the resistance factor induction upon an antibiotic challenge. As we have shown earlier, in the case of <italic toggle="yes">B. subtilis</italic> VmlR, the sequence identity of the regulatory uORF(MIN) is crucial for efficient induction upon a lincomycin challenge (<xref rid="B31" ref-type="bibr">31</xref>), despite this antibiotic not being known to act in a context-dependent manner. These insights, in turn, could potentially be leveraged for development of antibiotic variants with unnatural novel stalling profiles that are not detected by uORF-mediated attenuation mechanisms, and, therefore, do not trigger inducible resistance.</p></sec><sec sec-type="data-availability" id="SEC5"><title>DATA AVAILABILITY</title><p>Cryo-EM maps have been deposited in the Electron Microscopy Data Bank (EMDB) with the accession code EMD-16246. The molecular model is available from the RCSB PDB with the accession code 8BUU.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>gkad193_Supplemental_Files</label><media xlink:href="gkad193_supplemental_files.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="ACK1"><title>ACKNOWLEDGEMENTS</title><p>We thank Michael Hall for help with cryo-EM data collection and grid preparation, Farren Isaacs for providing the pRK24 plasmid (<xref rid="B74" ref-type="bibr">74</xref>) as well as Robert Fagan and Neil Fairweather for providing the pRPF185 plasmid. The electron microscopy data was collected at the Ume&#x000e5; Core Facility for Electron Microscopy, a node of the Cryo-EM Swedish National Facility, funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Ume&#x000e5; University.</p></ack><sec id="SEC6"><title>SUPPLEMENTARY DATA</title><p>
<ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad193#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p></sec><sec id="SEC7"><title>FUNDING</title><p>Deutsche Forschungsgemeinschaft (DFG) [WI3285/8-1 to D.N.W.]; Swedish Research Council (Vetenskapsr&#x000e5;det) [2019-01085 to G.C.A., 2017-03783 and 2021-01146 to V.H.]; Cancerfonden [20 0872 Pj to V.H.]; Estonian Research Council [PRG335 to V.H.]; National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI168228 to A.G.M.]; European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering [2014-2020.4.01.15-0013 to V.H.]; V.H. and D.N.W. groups are also supported by the Swedish Research Council [2018-00956 to V.H.]; Deutsche Zentrum f&#x000fc;r Luft- und Raumfahrt [DLR01Kl1820 to D.N.W.] within the RIBOTARGET consortium under the framework of JPIAMR; G.C.A. and V.H. were also supported by a project grant from the Knut and Alice Wallenberg Foundation [2020-0037 to G.C.A.]; H.T. was supported by JST, ACT X, Japan grant JP1159335; S.C. was supported by MEXT, JSPS Grant-in-Aid for Scientific Research [20H05926, 21K06053]; Institute for Fermentation, Osaka [G-2021-2-063]; N.O. was supported by MEXT, JSPS Grant-in-Aid for Scientific Research [21K07018]; K.J.Y.W. was supported by a National Science Scholarship (PhD) by the Agency for Science, Technology and Research, Singapore. Funding for open access charge: Swedish Research Council (Vetenskapsr&#x000e5;det) [2017-03783 to V.H.].</p><p>
<italic toggle="yes">Conflict of interest statement</italic>. A.G.M. is an inventor in a provisional patent application submitted by the President and Fellows of Harvard College covering oxepanoprolinamide antibiotics described in this work. A.G.M. has filed the following international patent applications: WO/2019/032936 &#x02018;Lincosamide Antibiotics and Uses Thereof&#x02019; and WO/2019/032956 &#x02018;Lincosamide Antibiotics and Uses Thereof&#x02019;. All other authors: none to declare.</p></sec><ref-list id="REF1"><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<collab>Antimicrobial Resistance Collaborators</collab>
<article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source>. <year>2022</year>; <volume>399</volume>:<fpage>629</fpage>&#x02013;<lpage>655</lpage>.<pub-id pub-id-type="pmid">35065702</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Arenz</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Wilson</surname><given-names>D.N.</given-names></string-name></person-group>
<article-title>Bacterial protein synthesis as a target for antibiotic inhibition</article-title>. <source>Cold Spring Harb. Perspect. Med.</source><year>2016</year>; <volume>6</volume>:<fpage>a025361</fpage>.<pub-id pub-id-type="pmid">27481773</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Zhou</surname><given-names>D.</given-names></string-name>, <string-name><surname>Steitz</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Polikanov</surname><given-names>Y.S.</given-names></string-name>, <string-name><surname>Gagnon</surname><given-names>M.G.</given-names></string-name></person-group>
<article-title>Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design</article-title>. <source>Annu. Rev. Biochem.</source><year>2018</year>; <volume>87</volume>:<fpage>451</fpage>&#x02013;<lpage>478</lpage>.<pub-id pub-id-type="pmid">29570352</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wilson</surname>
<given-names>D.N.</given-names>
</string-name>
</person-group>
<article-title>Ribosome-targeting antibiotics and mechanisms of bacterial resistance</article-title>. <source>Nat. Rev. Microbiol.</source><year>2014</year>; <volume>12</volume>:<fpage>35</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">24336183</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wilson</surname>
<given-names>D.N.</given-names>
</string-name>, <string-name><surname>Hauryliuk</surname><given-names>V.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name>, <string-name><surname>O&#x02019;Neill</surname><given-names>A.J</given-names></string-name></person-group>
<article-title>Target protection as a key antibiotic resistance mechanism</article-title>. <source>Nat. Rev. Microbiol.</source><year>2020</year>; <volume>18</volume>:<fpage>637</fpage>&#x02013;<lpage>648</lpage>.<pub-id pub-id-type="pmid">32587401</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schwarz</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Shen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kadlec</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Brenner&#x000a0;Michael</surname><given-names>G.</given-names></string-name>, <string-name><surname>Fessler</surname><given-names>A.T.</given-names></string-name>, <string-name><surname>Vester</surname><given-names>B.</given-names></string-name></person-group>
<article-title>Lincosamides, streptogramins, phenicols, and pleuromutilins: mode of action and mechanisms of resistance</article-title>. <source>Cold Spring Harb. Perspect. Med.</source><year>2016</year>; <volume>6</volume>:<fpage>a027037</fpage>.<pub-id pub-id-type="pmid">27549310</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Polikanov</surname>
<given-names>Y.S.</given-names>
</string-name>, <string-name><surname>Starosta</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Juette</surname><given-names>M.F.</given-names></string-name>, <string-name><surname>Altman</surname><given-names>R.B.</given-names></string-name>, <string-name><surname>Terry</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Burnett</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Dinos</surname><given-names>G.</given-names></string-name>, <string-name><surname>Reynolds</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Blanchard</surname><given-names>S.C.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Distinct tRNA accommodation intermediates observed on the ribosome with the antibiotics hygromycin A and A201A</article-title>. <source>Mol. Cell</source>. <year>2015</year>; <volume>58</volume>:<fpage>832</fpage>&#x02013;<lpage>844</lpage>.<pub-id pub-id-type="pmid">26028538</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kaminishi</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Schedlbauer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fabbretti</surname><given-names>A.</given-names></string-name>, <string-name><surname>Brandi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ochoa-Lizarralde</surname><given-names>B.</given-names></string-name>, <string-name><surname>He</surname><given-names>C.G.</given-names></string-name>, <string-name><surname>Milon</surname><given-names>P.</given-names></string-name>, <string-name><surname>Connell</surname><given-names>S.R.</given-names></string-name>, <string-name><surname>Gualerzi</surname><given-names>C.O.</given-names></string-name>, <string-name><surname>Fucini</surname><given-names>P.</given-names></string-name></person-group>
<article-title>Crystallographic characterization of the ribosomal binding site and molecular mechanism of action of Hygromycin A</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>10015</fpage>&#x02013;<lpage>10025</lpage>.<pub-id pub-id-type="pmid">26464437</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schlunzen</surname>
<given-names>F.</given-names>
</string-name>, <string-name><surname>Pyetan</surname><given-names>E.</given-names></string-name>, <string-name><surname>Fucini</surname><given-names>P.</given-names></string-name>, <string-name><surname>Yonath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Harms</surname><given-names>J.M.</given-names></string-name></person-group>
<article-title>Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from <italic toggle="yes">Deinococcus radiodurans</italic> in complex with tiamulin</article-title>. <source>Mol. Microbiol.</source><year>2004</year>; <volume>54</volume>:<fpage>1287</fpage>&#x02013;<lpage>1294</lpage>.<pub-id pub-id-type="pmid">15554968</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Macleod</surname>
<given-names>A.J.</given-names>
</string-name>, <string-name><surname>Ross</surname><given-names>H.B.</given-names></string-name>, <string-name><surname>Ozere</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Digout</surname><given-names>G.</given-names></string-name>, <string-name><surname>Van</surname><given-names>R.</given-names></string-name></person-group>
<article-title>Lincomycin: a new antibiotic active against Staphylococci and other gram-positive Cocci: clinical and laboratory studies</article-title>. <source>Can Med Assoc J</source>. <year>1964</year>; <volume>91</volume>:<fpage>1056</fpage>&#x02013;<lpage>1060</lpage>.<pub-id pub-id-type="pmid">14217764</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Phillips</surname>
<given-names>I.</given-names>
</string-name>
</person-group>
<article-title>Past and current use of clindamycin and lincomycin</article-title>. <source>J. Antimicrob. Chemother.</source><year>1981</year>; <volume>7</volume>(<issue>Suppl A</issue>):<fpage>11</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">7019190</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mitcheltree</surname>
<given-names>M.J.</given-names>
</string-name>, <string-name><surname>Pisipati</surname><given-names>A.</given-names></string-name>, <string-name><surname>Syroegin</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Silvestre</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Klepacki</surname><given-names>D.</given-names></string-name>, <string-name><surname>Mason</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Terwilliger</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Testolin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Pote</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>K.J.Y.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>A synthetic antibiotic class overcoming bacterial multidrug resistance</article-title>. <source>Nature</source>. <year>2021</year>; <volume>599</volume>:<fpage>507</fpage>&#x02013;<lpage>512</lpage>.<pub-id pub-id-type="pmid">34707295</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tu</surname>
<given-names>D.</given-names>
</string-name>, <string-name><surname>Blaha</surname><given-names>G.</given-names></string-name>, <string-name><surname>Moore</surname><given-names>P.B.</given-names></string-name>, <string-name><surname>Steitz</surname><given-names>T.A.</given-names></string-name></person-group>
<article-title>Structures of MLS<sub>B</sub>K antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance</article-title>. <source>Cell</source>. <year>2005</year>; <volume>121</volume>:<fpage>257</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">15851032</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Syroegin</surname>
<given-names>E.A.</given-names>
</string-name>, <string-name><surname>Flemmich</surname><given-names>L.</given-names></string-name>, <string-name><surname>Klepacki</surname><given-names>D.</given-names></string-name>, <string-name><surname>Vazquez-Laslop</surname><given-names>N.</given-names></string-name>, <string-name><surname>Micura</surname><given-names>R.</given-names></string-name>, <string-name><surname>Polikanov</surname><given-names>Y.S.</given-names></string-name></person-group>
<article-title>Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2022</year>; <volume>29</volume>:<fpage>152</fpage>&#x02013;<lpage>161</lpage>.<pub-id pub-id-type="pmid">35165455</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsai</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Stojkovic</surname><given-names>V.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Young</surname><given-names>I.D.</given-names></string-name>, <string-name><surname>Szal</surname><given-names>T.</given-names></string-name>, <string-name><surname>Klepacki</surname><given-names>D.</given-names></string-name>, <string-name><surname>Vazquez-Laslop</surname><given-names>N.</given-names></string-name>, <string-name><surname>Mankin</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Fraser</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Fujimori</surname><given-names>D.G.</given-names></string-name></person-group>
<article-title>Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2022</year>; <volume>29</volume>:<fpage>162</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">35165456</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ippolito</surname>
<given-names>J.A.</given-names>
</string-name>, <string-name><surname>Kanyo</surname><given-names>Z.F.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Franceschi</surname><given-names>F.J.</given-names></string-name>, <string-name><surname>Moore</surname><given-names>P.B.</given-names></string-name>, <string-name><surname>Steitz</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Duffy</surname><given-names>E.M.</given-names></string-name></person-group>
<article-title>Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit</article-title>. <source>J. Med. Chem.</source><year>2008</year>; <volume>51</volume>:<fpage>3353</fpage>&#x02013;<lpage>3356</lpage>.<pub-id pub-id-type="pmid">18494460</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Beckert</surname>
<given-names>B.</given-names>
</string-name>, <string-name><surname>Leroy</surname><given-names>E.C.</given-names></string-name>, <string-name><surname>Sothiselvam</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bock</surname><given-names>L.V.</given-names></string-name>, <string-name><surname>Svetlov</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Graf</surname><given-names>M.</given-names></string-name>, <string-name><surname>Arenz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Abdelshahid</surname><given-names>M.</given-names></string-name>, <string-name><surname>Seip</surname><given-names>B.</given-names></string-name>, <string-name><surname>Grubmuller</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>4466</fpage>.<pub-id pub-id-type="pmid">34294725</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vazquez-Laslop</surname>
<given-names>N.</given-names>
</string-name>, <string-name><surname>Mankin</surname><given-names>A.S.</given-names></string-name></person-group>
<article-title>Context-specific action of ribosomal antibiotics</article-title>. <source>Annu. Rev. Microbiol.</source><year>2018</year>; <volume>72</volume>:<fpage>185</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">29906204</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Harms</surname>
<given-names>J.M.</given-names>
</string-name>, <string-name><surname>Schlunzen</surname><given-names>F.</given-names></string-name>, <string-name><surname>Fucini</surname><given-names>P.</given-names></string-name>, <string-name><surname>Bartels</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yonath</surname><given-names>A.</given-names></string-name></person-group>
<article-title>Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin</article-title>. <source>BMC Biol.</source><year>2004</year>; <volume>2</volume>:<fpage>4</fpage>.<pub-id pub-id-type="pmid">15059283</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ero</surname>
<given-names>R.</given-names>
</string-name>, <string-name><surname>Kumar</surname><given-names>V.</given-names></string-name>, <string-name><surname>Su</surname><given-names>W.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.G.</given-names></string-name></person-group>
<article-title>Ribosome protection by ABC-F proteins-molecular mechanism and potential drug design</article-title>. <source>Protein Sci.</source><year>2019</year>; <volume>28</volume>:<fpage>684</fpage>&#x02013;<lpage>693</lpage>.<pub-id pub-id-type="pmid">30746819</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bo&#x000eb;l</surname>
<given-names>G.</given-names>
</string-name>, <string-name><surname>Smith</surname><given-names>P.C.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>W.</given-names></string-name>, <string-name><surname>Englander</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hashem</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Testa</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Fischer</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Wieden</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Frank</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>The ABC-F protein EttA gates ribosome entry into the translation elongation cycle</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2014</year>; <volume>21</volume>:<fpage>143</fpage>&#x02013;<lpage>151</lpage>.<pub-id pub-id-type="pmid">24389466</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chen</surname>
<given-names>B.</given-names>
</string-name>, <string-name><surname>Bo&#x000eb;l</surname><given-names>G.</given-names></string-name>, <string-name><surname>Hashem</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>W.</given-names></string-name>, <string-name><surname>Fei</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gonzalez</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Frank</surname><given-names>J</given-names></string-name></person-group>
<article-title>EttA regulates translation by binding the ribosomal E site and restricting ribosome-tRNA dynamics</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2014</year>; <volume>21</volume>:<fpage>152</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">24389465</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gamper</surname><given-names>H.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>Y.M.</given-names></string-name>, <string-name><surname>Sacchettini</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group>
<article-title>Interplay between an ATP-binding cassette F protein and the ribosome from <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title>. <source>Nat. Commun.</source><year>2022</year>; <volume>13</volume>:<fpage>432</fpage>.<pub-id pub-id-type="pmid">35064151</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Murina</surname>
<given-names>V.</given-names>
</string-name>, <string-name><surname>Kasari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H.</given-names></string-name>, <string-name><surname>Hinnu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Saha</surname><given-names>C.K.</given-names></string-name>, <string-name><surname>Grimshaw</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Seki</surname><given-names>T.</given-names></string-name>, <string-name><surname>Reith</surname><given-names>M.</given-names></string-name>, <string-name><surname>Putrins</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tenson</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>ABCF atpases involved in protein synthesis, ribosome assembly and antibiotic resistance: structural and functional diversification across the tree of life</article-title>. <source>J. Mol. Biol.</source><year>2019</year>; <volume>431</volume>:<fpage>3568</fpage>&#x02013;<lpage>3590</lpage>.<pub-id pub-id-type="pmid">30597160</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gentry</surname>
<given-names>D.R.</given-names>
</string-name>, <string-name><surname>McCloskey</surname><given-names>L.</given-names></string-name>, <string-name><surname>Gwynn</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Rittenhouse</surname><given-names>S.F.</given-names></string-name>, <string-name><surname>Scangarella</surname><given-names>N.</given-names></string-name>, <string-name><surname>Shawar</surname><given-names>R.</given-names></string-name>, <string-name><surname>Holmes</surname><given-names>D.J.</given-names></string-name></person-group>
<article-title>Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in <italic toggle="yes">Staphylococcus aureus</italic></article-title>. <source>Antimicrob. Agents Chemother.</source><year>2008</year>; <volume>52</volume>:<fpage>4507</fpage>&#x02013;<lpage>4509</lpage>.<pub-id pub-id-type="pmid">18838584</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Crowe-McAuliffe</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Murina</surname><given-names>V.</given-names></string-name>, <string-name><surname>Turnbull</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Kasari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mohamad</surname><given-names>M.</given-names></string-name>, <string-name><surname>Polte</surname><given-names>C.</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H.</given-names></string-name>, <string-name><surname>Vaitkevicius</surname><given-names>K.</given-names></string-name>, <string-name><surname>Johansson</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ignatova</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Structural basis of ABCF-mediated resistance to pleuromutilin, lincosamide, and streptogramin A antibiotics in gram-positive pathogens</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>3577</fpage>.<pub-id pub-id-type="pmid">34117249</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dar</surname>
<given-names>D.</given-names>
</string-name>, <string-name><surname>Shamir</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mellin</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Koutero</surname><given-names>M.</given-names></string-name>, <string-name><surname>Stern-Ginossar</surname><given-names>N.</given-names></string-name>, <string-name><surname>Cossart</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sorek</surname><given-names>R.</given-names></string-name></person-group>
<article-title>Term-seq reveals abundant ribo-regulation of antibiotics resistance in bacteria</article-title>. <source>Science</source>. <year>2016</year>; <volume>352</volume>:<fpage>aad9822</fpage>.<pub-id pub-id-type="pmid">27120414</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ohki</surname>
<given-names>R.</given-names>
</string-name>, <string-name><surname>Tateno</surname><given-names>K.</given-names></string-name>, <string-name><surname>Takizawa</surname><given-names>T.</given-names></string-name>, <string-name><surname>Aiso</surname><given-names>T.</given-names></string-name>, <string-name><surname>Murata</surname><given-names>M.</given-names></string-name></person-group>
<article-title>Transcriptional termination control of a novel ABC transporter gene involved in antibiotic resistance in <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source>J. Bacteriol.</source><year>2005</year>; <volume>187</volume>:<fpage>5946</fpage>&#x02013;<lpage>5954</lpage>.<pub-id pub-id-type="pmid">16109936</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Koberska</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Vesela</surname><given-names>L.</given-names></string-name>, <string-name><surname>Vimberg</surname><given-names>V.</given-names></string-name>, <string-name><surname>Lenart</surname><given-names>J.</given-names></string-name>, <string-name><surname>Vesela</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kamenik</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Janata</surname><given-names>J.</given-names></string-name>, <string-name><surname>Balikova&#x000a0;Novotna</surname><given-names>G.</given-names></string-name></person-group>
<article-title>Beyond self-resistance: ABCF atpase LmrC is a signal-transducing component of an antibiotic-driven signaling cascade accelerating the onset of lincomycin biosynthesis</article-title>. <source>mBio</source>. <year>2021</year>; <volume>12</volume>:<fpage>e0173121</fpage>.<pub-id pub-id-type="pmid">34488446</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cai</surname>
<given-names>X.</given-names>
</string-name>, <string-name><surname>Zhan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>B.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>J.</given-names></string-name></person-group>
<article-title>Expression of ribosomal protection protein RppA is regulated by a ribosome-dependent ribo-regulator and two mistranslation products</article-title>. <source>Environ. Microbiol.</source><year>2021</year>; <volume>23</volume>:<fpage>696</fpage>&#x02013;<lpage>712</lpage>.<pub-id pub-id-type="pmid">32592275</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Takada</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Mandell</surname><given-names>Z.F.</given-names></string-name>, <string-name><surname>Yakhnin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Glazyrina</surname><given-names>A.</given-names></string-name>, <string-name><surname>Chiba</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kurata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>K.J.Y.</given-names></string-name>, <string-name><surname>Tresco</surname><given-names>B.I.C.</given-names></string-name>, <string-name><surname>Myers</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Aktinson</surname><given-names>G.C.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Expression of <italic toggle="yes">Bacillus subtilis</italic> ABCF antibiotic resistance factor VmlR is regulated by RNA polymerase pausing, transcription attenuation, translation attenuation and (p) ppGpp</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>6174</fpage>&#x02013;<lpage>6189</lpage>.<pub-id pub-id-type="pmid">35699226</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vimberg</surname>
<given-names>V.</given-names>
</string-name>, <string-name><surname>Cavanagh</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Novotna</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lenart</surname><given-names>J.</given-names></string-name>, <string-name><surname>Nguyen&#x000a0;Thi&#x000a0;Ngoc</surname><given-names>B.</given-names></string-name>, <string-name><surname>Vesela</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pain</surname><given-names>M.</given-names></string-name>, <string-name><surname>Koberska</surname><given-names>M.</given-names></string-name>, <string-name><surname>Balikova&#x000a0;Novotna</surname><given-names>G.</given-names></string-name></person-group>
<article-title>Ribosome-mediated attenuation of <italic toggle="yes">vga(A)</italic> expression is shaped by the antibiotic resistance specificity of Vga(A) protein variants</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2020</year>; <volume>64</volume>:<fpage>e00666</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">32816732</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Crowe-McAuliffe</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Murina</surname><given-names>V.</given-names></string-name>, <string-name><surname>Turnbull</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Huch</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kasari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H.</given-names></string-name>, <string-name><surname>Nersisyan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Sundsfjord</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hegstad</surname><given-names>K.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics</article-title>. <source>Nat. Commun.</source><year>2022</year>; <volume>13</volume>:<fpage>1860</fpage>.<pub-id pub-id-type="pmid">35387982</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Crowe-McAuliffe</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Graf</surname><given-names>M.</given-names></string-name>, <string-name><surname>Huter</surname><given-names>P.</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H.</given-names></string-name>, <string-name><surname>Abdelshahid</surname><given-names>M.</given-names></string-name>, <string-name><surname>Novacek</surname><given-names>J.</given-names></string-name>, <string-name><surname>Murina</surname><given-names>V.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name>, <string-name><surname>Hauryliuk</surname><given-names>V.</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>D.N.</given-names></string-name></person-group>
<article-title>Structural basis for antibiotic resistance mediated by the <italic toggle="yes">Bacillus subtilis</italic> ABCF ATPase VmlR</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2018</year>; <volume>115</volume>:<fpage>8978</fpage>&#x02013;<lpage>8983</lpage>.<pub-id pub-id-type="pmid">30126986</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Novotna</surname>
<given-names>G.</given-names>
</string-name>, <string-name><surname>Janata</surname><given-names>J.</given-names></string-name></person-group>
<article-title>A new evolutionary variant of the streptogramin A resistance protein, Vga(A)<sub>LC</sub>, from <italic toggle="yes">Staphylococcus haemoly</italic><italic toggle="yes">t</italic><italic toggle="yes">icus</italic> with shifted substrate specificity towards lincosamides</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2006</year>; <volume>50</volume>:<fpage>4070</fpage>&#x02013;<lpage>4076</lpage>.<pub-id pub-id-type="pmid">17015629</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Singh</surname>
<given-names>K.V.</given-names>
</string-name>, <string-name><surname>Weinstock</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Murray</surname><given-names>B.E.</given-names></string-name></person-group>
<article-title>An <italic toggle="yes">Enterococcus faecalis</italic> ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2002</year>; <volume>46</volume>:<fpage>1845</fpage>&#x02013;<lpage>1850</lpage>.<pub-id pub-id-type="pmid">12019099</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Antonelli</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>D&#x02019;Andrea</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Brenciani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Galeotti</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Morroni</surname><given-names>G.</given-names></string-name>, <string-name><surname>Pollini</surname><given-names>S.</given-names></string-name>, <string-name><surname>Varaldo</surname><given-names>P.E.</given-names></string-name>, <string-name><surname>Rossolini</surname><given-names>G.M.</given-names></string-name></person-group>
<article-title>Characterization of <italic toggle="yes">poxtA</italic>, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin</article-title>. <source>J. Antimicrob. Chemother.</source><year>2018</year>; <volume>73</volume>:<fpage>1763</fpage>&#x02013;<lpage>1769</lpage>.<pub-id pub-id-type="pmid">29635422</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</string-name>, <string-name><surname>Lv</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schwarz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Q.</given-names></string-name>, <string-name><surname>He</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>A novel gene, <italic toggle="yes">optrA</italic>, that confers transferable resistance to oxazolidinones and phenicols and its presence in <italic toggle="yes">Enterococcus faecalis</italic> and <italic toggle="yes">Enter</italic><italic toggle="yes">o</italic><italic toggle="yes">coccus faecium</italic> of human and animal origin</article-title>. <source>J. Antimicrob. Chemother.</source><year>2015</year>; <volume>70</volume>:<fpage>2182</fpage>&#x02013;<lpage>2190</lpage>.<pub-id pub-id-type="pmid">25977397</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ross</surname>
<given-names>J.I.</given-names>
</string-name>, <string-name><surname>Eady</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Cove</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Cunliffe</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Baumberg</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wootton</surname><given-names>J.C.</given-names></string-name></person-group>
<article-title>Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family</article-title>. <source>Mol. Microbiol.</source><year>1990</year>; <volume>4</volume>:<fpage>1207</fpage>&#x02013;<lpage>1214</lpage>.<pub-id pub-id-type="pmid">2233255</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rosteck</surname>
<given-names>P.R.</given-names>
</string-name>, <string-name><surname>Reynolds</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Hershberger</surname><given-names>C.L</given-names></string-name></person-group>
<article-title>Homology between proteins controlling <italic toggle="yes">Streptomyces fradiae</italic> tylosin resistance and ATP-binding transport</article-title>. <source>Gene</source>. <year>1991</year>; <volume>102</volume>:<fpage>27</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">1864505</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Su</surname>
<given-names>W.</given-names>
</string-name>, <string-name><surname>Kumar</surname><given-names>V.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ero</surname><given-names>R.</given-names></string-name>, <string-name><surname>Serra</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>B.S.T.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>A.S.W.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sze</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Ribosome protection by antibiotic resistance ATP-binding cassette protein</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2018</year>; <volume>115</volume>:<fpage>5157</fpage>&#x02013;<lpage>5162</lpage>.<pub-id pub-id-type="pmid">29712846</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Murina</surname>
<given-names>V.</given-names>
</string-name>, <string-name><surname>Kasari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hauryliuk</surname><given-names>V.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name></person-group>
<article-title>Antibiotic resistance ABCF proteins reset the peptidyl transferase centre of the ribosome to counter translational arrest</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>3753</fpage>&#x02013;<lpage>3763</lpage>.<pub-id pub-id-type="pmid">29415157</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mohamad</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Nicholson</surname><given-names>D.</given-names></string-name>, <string-name><surname>Saha</surname><given-names>C.K.</given-names></string-name>, <string-name><surname>Hauryliuk</surname><given-names>V.</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name>, <string-name><surname>Ranson</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>O&#x02019;Neill</surname><given-names>A.J</given-names></string-name></person-group>
<article-title>Sal-type ABC-F proteins: intrinsic and common mediators of pleuromutilin resistance by target protection in staphylococci</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>2128</fpage>&#x02013;<lpage>2142</lpage>.<pub-id pub-id-type="pmid">35137182</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Long</surname>
<given-names>K.S.</given-names>
</string-name>, <string-name><surname>Poehlsgaard</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kehrenberg</surname><given-names>C.</given-names></string-name>, <string-name><surname>Schwarz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vester</surname><given-names>B.</given-names></string-name></person-group>
<article-title>The cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2006</year>; <volume>50</volume>:<fpage>2500</fpage>&#x02013;<lpage>2505</lpage>.<pub-id pub-id-type="pmid">16801432</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Maravi&#x00107;</surname>
<given-names>G.</given-names>
</string-name>
</person-group>
<article-title>Macrolide resistance based on the Erm-mediated rRNA methylation</article-title>. <source>Curr. Drug Targets Infect. Disord.</source><year>2004</year>; <volume>4</volume>:<fpage>193</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="pmid">15379730</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schwarz</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Werckenthin</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kehrenberg</surname><given-names>C.</given-names></string-name></person-group>
<article-title>Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in <italic toggle="yes">Staphylococcus sciuri</italic></article-title>. <source>Antimicrob. Agents Chemother.</source><year>2000</year>; <volume>44</volume>:<fpage>2530</fpage>&#x02013;<lpage>2533</lpage>.<pub-id pub-id-type="pmid">10952608</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Uchiyama</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Weisblum</surname><given-names>B.</given-names></string-name></person-group>
<article-title>N-methyl transferase of <italic toggle="yes">Streptomyces erythraeus</italic> that confers resistance to the macrolide-lincosamide-streptogramin B antibiotics: amino acid sequence and its homology to cognate R-factor enzymes from pathogenic bacilli and cocci</article-title>. <source>Gene</source>. <year>1985</year>; <volume>38</volume>:<fpage>103</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">3934045</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Brodiazhenko</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Turnbull</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>K.J.Y.</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H.</given-names></string-name>, <string-name><surname>Tresco</surname><given-names>B.I.C.</given-names></string-name>, <string-name><surname>Tenson</surname><given-names>T.</given-names></string-name>, <string-name><surname>Myers</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Hauryliuk</surname><given-names>V.</given-names></string-name></person-group>
<article-title>Synthetic oxepanoprolinamide iboxamycin is active against <italic toggle="yes">Listeria monocytogenes</italic> despite the intrinsic resistance mediated by VgaL/Lmo0919 ABCF atpase</article-title>. <source>JAC Antimicrob. Resist.</source><year>2022</year>; <volume>4</volume>:<fpage>dlac061</fpage>.<pub-id pub-id-type="pmid">35733912</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gumkowski</surname>
<given-names>J.D.</given-names>
</string-name>, <string-name><surname>Martinie</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Corrigan</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bauerle</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Almarei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Booker</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Silakov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Krebs</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boal</surname><given-names>A.K.</given-names></string-name></person-group>
<article-title>Analysis of RNA methylation by phylogenetically diverse <italic toggle="yes">cfr</italic> radical S-adenosylmethionine enzymes reveals an iron-binding accessory domain in a clostridial enzyme</article-title>. <source>Biochemistry</source>. <year>2019</year>; <volume>58</volume>:<fpage>3169</fpage>&#x02013;<lpage>3184</lpage>.<pub-id pub-id-type="pmid">31246421</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kehrenberg</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Aarestrup</surname><given-names>F.M.</given-names></string-name>, <string-name><surname>Schwarz</surname><given-names>S.</given-names></string-name></person-group>
<article-title>IS<italic toggle="yes">21-558</italic> insertion sequences are involved in the mobility of the multiresistance gene <italic toggle="yes">cfr</italic></article-title>. <source>Antimicrob. Agents Chemother.</source><year>2007</year>; <volume>51</volume>:<fpage>483</fpage>&#x02013;<lpage>487</lpage>.<pub-id pub-id-type="pmid">17145796</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Johnson</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Samore</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Farrow</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Killgore</surname><given-names>G.E.</given-names></string-name>, <string-name><surname>Tenover</surname><given-names>F.C.</given-names></string-name>, <string-name><surname>Lyras</surname><given-names>D.</given-names></string-name>, <string-name><surname>Rood</surname><given-names>J.I.</given-names></string-name>, <string-name><surname>DeGirolami</surname><given-names>P.</given-names></string-name>, <string-name><surname>Baltch</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Rafferty</surname><given-names>M.E.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Epidemics of diarrhea caused by a clindamycin-resistant strain of <italic toggle="yes">Clostridium difficile</italic> in four hospitals</article-title>. <source>N. Engl. J. Med.</source><year>1999</year>; <volume>341</volume>:<fpage>1645</fpage>&#x02013;<lpage>1651</lpage>.<pub-id pub-id-type="pmid">10572152</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Barrasa</surname>
<given-names>M.I.</given-names>
</string-name>, <string-name><surname>Tercero</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Lacalle</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Jimenez</surname><given-names>A.</given-names></string-name></person-group>
<article-title>The <italic toggle="yes">ard1</italic> gene from <italic toggle="yes">Streptomyces capreolus</italic> encodes a polypeptide of the ABC-transporters superfamily which confers resistance to the aminonucleoside antibiotic A201A</article-title>. <source>Eur. J. Biochem.</source><year>1995</year>; <volume>228</volume>:<fpage>562</fpage>&#x02013;<lpage>569</lpage>.<pub-id pub-id-type="pmid">7737149</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Saugar</surname>
<given-names>I.</given-names>
</string-name>, <string-name><surname>Sanz</surname><given-names>E.</given-names></string-name>, <string-name><surname>Rubio</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Espinosa</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Jimenez</surname><given-names>A.</given-names></string-name></person-group>
<article-title>Identification of a set of genes involved in the biosynthesis of the aminonucleoside moiety of antibiotic A201A from <italic toggle="yes">Streptomyces capreolus</italic></article-title>. <source>Eur. J. Biochem.</source><year>2002</year>; <volume>269</volume>:<fpage>5527</fpage>&#x02013;<lpage>5535</lpage>.<pub-id pub-id-type="pmid">12423351</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fuchs</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Lamm-Schmidt</surname><given-names>V.</given-names></string-name>, <string-name><surname>Sulzer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ponath</surname><given-names>F.</given-names></string-name>, <string-name><surname>Jenniches</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kirk</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Fagan</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Barquist</surname><given-names>L.</given-names></string-name>, <string-name><surname>Vogel</surname><given-names>J.</given-names></string-name>, <string-name><surname>Faber</surname><given-names>F.</given-names></string-name></person-group>
<article-title>An RNA-centric global view of <italic toggle="yes">Clostridioides difficile</italic> reveals broad activity of Hfq in a clinically important gram-positive bacterium</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>; <volume>118</volume>:<fpage>e2103579118</fpage>.<pub-id pub-id-type="pmid">34131082</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Farrow</surname>
<given-names>K.A.</given-names>
</string-name>, <string-name><surname>Lyras</surname><given-names>D.</given-names></string-name>, <string-name><surname>Rood</surname><given-names>J.I.</given-names></string-name></person-group>
<article-title>Genomic analysis of the erythromycin resistance element Tn5398 from <italic toggle="yes">Clostridium difficile</italic></article-title>. <source>Microbiology (Reading)</source>. <year>2001</year>; <volume>147</volume>:<fpage>2717</fpage>&#x02013;<lpage>2728</lpage>.<pub-id pub-id-type="pmid">11577151</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bishara</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Peled</surname><given-names>N.</given-names></string-name>, <string-name><surname>Pitlik</surname><given-names>S.</given-names></string-name>, <string-name><surname>Samra</surname><given-names>Z.</given-names></string-name></person-group>
<article-title>Mortality of patients with antibiotic-associated diarrhoea: the impact of <italic toggle="yes">Clostridium difficile</italic></article-title>. <source>J. Hosp. Infect.</source><year>2008</year>; <volume>68</volume>:<fpage>308</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">18353491</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Buffie</surname>
<given-names>C.G.</given-names>
</string-name>, <string-name><surname>Jarchum</surname><given-names>I.</given-names></string-name>, <string-name><surname>Equinda</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lipuma</surname><given-names>L.</given-names></string-name>, <string-name><surname>Gobourne</surname><given-names>A.</given-names></string-name>, <string-name><surname>Viale</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ubeda</surname><given-names>C.</given-names></string-name>, <string-name><surname>Xavier</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pamer</surname><given-names>E.G.</given-names></string-name></person-group>
<article-title>Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to <italic toggle="yes">Clostridium difficile</italic>-induced colitis</article-title>. <source>Infect. Immun.</source><year>2012</year>; <volume>80</volume>:<fpage>62</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">22006564</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Duffy</surname>
<given-names>C.R.</given-names>
</string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Andrikopoulou</surname><given-names>M.</given-names></string-name>, <string-name><surname>Stern-Ascher</surname><given-names>C.N.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Goffman</surname><given-names>D.</given-names></string-name>, <string-name><surname>D&#x02019;Alton</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>A.M.</given-names></string-name></person-group>
<article-title>Clindamycin, gentamicin, and risk of <italic toggle="yes">Clostridium difficile</italic> infection and acute kidney injury during delivery hospitalizations</article-title>. <source>Obstet. Gynecol.</source><year>2020</year>; <volume>135</volume>:<fpage>59</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">31809424</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sullivan</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Edlund</surname><given-names>C.</given-names></string-name>, <string-name><surname>Nord</surname><given-names>C.E.</given-names></string-name></person-group>
<article-title>Effect of antimicrobial agents on the ecological balance of human microflora</article-title>. <source>Lancet Infect. Dis.</source><year>2001</year>; <volume>1</volume>:<fpage>101</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">11871461</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Egorov</surname>
<given-names>A.A.</given-names>
</string-name>, <string-name><surname>Sakharova</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Anisimova</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Dmitriev</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Gladyshev</surname><given-names>V.N.</given-names></string-name>, <string-name><surname>Kulakovskiy</surname><given-names>I.V.</given-names></string-name></person-group>
<article-title>svist4get: a simple visualization tool for genomic tracks from sequencing experiments</article-title>. <source>BMC Bioinformatics</source>. <year>2019</year>; <volume>20</volume>:<fpage>113</fpage>.<pub-id pub-id-type="pmid">30841857</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Egorov</surname>
<given-names>A.A.</given-names>
</string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name></person-group>
<article-title>uORF4u: a tool for annotation of conserved upstream open reading frames</article-title>. <year>2022</year>; <comment>bioRxiv doi:</comment><comment>28 October 2022, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/2022.10.27.514069</pub-id>.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Camacho</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Coulouris</surname><given-names>G.</given-names></string-name>, <string-name><surname>Avagyan</surname><given-names>V.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>N.</given-names></string-name>, <string-name><surname>Papadopoulos</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bealer</surname><given-names>K.</given-names></string-name>, <string-name><surname>Madden</surname><given-names>T.L.</given-names></string-name></person-group>
<article-title>BLAST+: architecture and applications</article-title>. <source>BMC Bioinformatics</source>. <year>2009</year>; <volume>10</volume>:<fpage>421</fpage>.<pub-id pub-id-type="pmid">20003500</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Katoh</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Standley</surname><given-names>D.M.</given-names></string-name></person-group>
<article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title>. <source>Mol. Biol. Evol.</source><year>2013</year>; <volume>30</volume>:<fpage>772</fpage>&#x02013;<lpage>780</lpage>.<pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</string-name>, <string-name><surname>Feng</surname><given-names>T.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lam</surname><given-names>T.T.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>ggmsa: a visual exploration tool for multiple sequence alignment and associated data</article-title>. <source>Brief Bioinform</source>. <year>2022</year>; <volume>23</volume>:<fpage>bbac222</fpage>.<pub-id pub-id-type="pmid">35671504</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tareen</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Kinney</surname><given-names>J.B.</given-names></string-name></person-group>
<article-title>Logomaker: beautiful sequence logos in Python</article-title>. <source>Bioinformatics</source>. <year>2020</year>; <volume>36</volume>:<fpage>2272</fpage>&#x02013;<lpage>2274</lpage>.<pub-id pub-id-type="pmid">31821414</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gruber</surname>
<given-names>A.R.</given-names>
</string-name>, <string-name><surname>Lorenz</surname><given-names>R.</given-names></string-name>, <string-name><surname>Bernhart</surname><given-names>S.H.</given-names></string-name>, <string-name><surname>Neubock</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hofacker</surname><given-names>I.L.</given-names></string-name></person-group>
<article-title>The Vienna RNA websuite</article-title>. <source>Nucleic Acids Res.</source><year>2008</year>; <volume>36</volume>:<fpage>W70</fpage>&#x02013;<lpage>W74</lpage>.<pub-id pub-id-type="pmid">18424795</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Peltier</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Hamiot</surname><given-names>A.</given-names></string-name>, <string-name><surname>Garneau</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Boudry</surname><given-names>P.</given-names></string-name>, <string-name><surname>Maikova</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hajnsdorf</surname><given-names>E.</given-names></string-name>, <string-name><surname>Fortier</surname><given-names>L.C.</given-names></string-name>, <string-name><surname>Dupuy</surname><given-names>B.</given-names></string-name>, <string-name><surname>Soutourina</surname><given-names>O.</given-names></string-name></person-group>
<article-title>Type I toxin-antitoxin systems contribute to the maintenance of mobile genetic elements in <italic toggle="yes">Clostridioides difficile</italic></article-title>. <source>Commun. Biol.</source><year>2020</year>; <volume>3</volume>:<fpage>718</fpage>.<pub-id pub-id-type="pmid">33247281</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Larsson</surname>
<given-names>A.</given-names>
</string-name>
</person-group>
<article-title>AliView: a fast and lightweight alignment viewer and editor for large datasets</article-title>. <source>Bioinformatics</source>. <year>2014</year>; <volume>30</volume>:<fpage>3276</fpage>&#x02013;<lpage>3278</lpage>.<pub-id pub-id-type="pmid">25095880</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Waterhouse</surname>
<given-names>A.M.</given-names>
</string-name>, <string-name><surname>Procter</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Clamp</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barton</surname><given-names>G.J.</given-names></string-name></person-group>
<article-title>Jalview Version 2&#x02013;a multiple sequence alignment editor and analysis workbench</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>1189</fpage>&#x02013;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">19151095</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Capella-Gutierrez</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Silla-Martinez</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Gabaldon</surname><given-names>T.</given-names></string-name></person-group>
<article-title>trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>1972</fpage>&#x02013;<lpage>1973</lpage>.<pub-id pub-id-type="pmid">19505945</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Miller</surname>
<given-names>M.A.</given-names>
</string-name>, <string-name><surname>Pfeiffer</surname><given-names>W.</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>T.</given-names></string-name></person-group>
<source>2010 Gateway Computing Environments Workshop (GCE)</source>. <year>2010</year>; <fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Minh</surname>
<given-names>B.Q.</given-names>
</string-name>, <string-name><surname>Schmidt</surname><given-names>H.A.</given-names></string-name>, <string-name><surname>Chernomor</surname><given-names>O.</given-names></string-name>, <string-name><surname>Schrempf</surname><given-names>D.</given-names></string-name>, <string-name><surname>Woodhams</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Haeseler</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lanfear</surname><given-names>R.</given-names></string-name></person-group>
<article-title>IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era</article-title>. <source>Mol. Biol. Evol.</source><year>2020</year>; <volume>37</volume>:<fpage>1530</fpage>&#x02013;<lpage>1534</lpage>.<pub-id pub-id-type="pmid">32011700</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Price</surname>
<given-names>M.N.</given-names>
</string-name>, <string-name><surname>Dehal</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Arkin</surname><given-names>A.P.</given-names></string-name></person-group>
<article-title>FastTree 2&#x02013;approximately maximum-likelihood trees for large alignments</article-title>. <source>PLoS One</source>. <year>2010</year>; <volume>5</volume>:<fpage>e9490</fpage>.<pub-id pub-id-type="pmid">20224823</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ma</surname>
<given-names>N.J.</given-names>
</string-name>, <string-name><surname>Moonan</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Isaacs</surname><given-names>F.J.</given-names></string-name></person-group>
<article-title>Precise manipulation of bacterial chromosomes by conjugative assembly genome engineering</article-title>. <source>Nat. Protoc.</source><year>2014</year>; <volume>9</volume>:<fpage>2285</fpage>&#x02013;<lpage>2300</lpage>.<pub-id pub-id-type="pmid">25188631</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nariya</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Miyata</surname><given-names>S.</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tamai</surname><given-names>E.</given-names></string-name>, <string-name><surname>Okabe</surname><given-names>A.</given-names></string-name></person-group>
<article-title>Development and application of a method for counterselectable in-frame deletion in <italic toggle="yes">Clostridium perfringens</italic></article-title>. <source>Appl. Environ. Microbiol.</source><year>2011</year>; <volume>77</volume>:<fpage>1375</fpage>&#x02013;<lpage>1382</lpage>.<pub-id pub-id-type="pmid">21183644</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Obana</surname>
<given-names>N.</given-names>
</string-name>, <string-name><surname>Nakamura</surname><given-names>K.</given-names></string-name>, <string-name><surname>Nomura</surname><given-names>N.</given-names></string-name></person-group>
<article-title>Temperature-regulated heterogeneous extracellular matrix gene expression defines biofilm morphology in <italic toggle="yes">Clostridium perfringens</italic></article-title>. <source>NPJ Biofilms Microbiomes</source>. <year>2020</year>; <volume>6</volume>:<fpage>29</fpage>.<pub-id pub-id-type="pmid">32737303</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fagan</surname>
<given-names>R.P.</given-names>
</string-name>, <string-name><surname>Fairweather</surname><given-names>N.F.</given-names></string-name></person-group>
<article-title>
<italic toggle="yes">Clostridium difficile</italic> has two parallel and essential Sec secretion systems</article-title>. <source>J. Biol. Chem.</source><year>2011</year>; <volume>286</volume>:<fpage>27483</fpage>&#x02013;<lpage>27493</lpage>.<pub-id pub-id-type="pmid">21659510</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bannam</surname>
<given-names>T.L.</given-names>
</string-name>, <string-name><surname>Rood</surname><given-names>J.I.</given-names></string-name></person-group>
<article-title>
<italic toggle="yes">Clostri</italic>
<italic toggle="yes">d</italic>
<italic toggle="yes">ium perfringens-Escherichia coli</italic> shuttle vectors that carry single antibiotic resistance determinants</article-title>. <source>Plasmid</source>. <year>1993</year>; <volume>29</volume>:<fpage>233</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">8356117</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ransom</surname>
<given-names>E.M.</given-names>
</string-name>, <string-name><surname>Ellermeier</surname><given-names>C.D.</given-names></string-name>, <string-name><surname>Weiss</surname><given-names>D.S.</given-names></string-name></person-group>
<article-title>Use of mCherry Red fluorescent protein for studies of protein localization and gene expression in <italic toggle="yes">Clostridium difficile</italic></article-title>. <source>Appl. Environ. Microbiol.</source><year>2015</year>; <volume>81</volume>:<fpage>1652</fpage>&#x02013;<lpage>1660</lpage>.<pub-id pub-id-type="pmid">25527559</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Candiano</surname>
<given-names>G.</given-names>
</string-name>, <string-name><surname>Bruschi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Musante</surname><given-names>L.</given-names></string-name>, <string-name><surname>Santucci</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ghiggeri</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Carnemolla</surname><given-names>B.</given-names></string-name>, <string-name><surname>Orecchia</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zardi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Righetti</surname><given-names>P.G.</given-names></string-name></person-group>
<article-title>Blue silver: a very sensitive colloidal coomassie G-250 staining for proteome analysis</article-title>. <source>Electrophoresis</source>. <year>2004</year>; <volume>25</volume>:<fpage>1327</fpage>&#x02013;<lpage>1333</lpage>.<pub-id pub-id-type="pmid">15174055</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zheng</surname>
<given-names>S.Q.</given-names>
</string-name>, <string-name><surname>Palovcak</surname><given-names>E.</given-names></string-name>, <string-name><surname>Armache</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Verba</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Agard</surname><given-names>D.A.</given-names></string-name></person-group>
<article-title>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</article-title>. <source>Nat Methods</source>. <year>2017</year>; <volume>14</volume>:<fpage>331</fpage>&#x02013;<lpage>332</lpage>.<pub-id pub-id-type="pmid">28250466</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</string-name>
</person-group>
<article-title>Gctf: real-time CTF determination and correction</article-title>. <source>J Struct Biol</source>. <year>2016</year>; <volume>193</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">26592709</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Scheres</surname>
<given-names>S.H.</given-names>
</string-name>
</person-group>
<article-title>RELION: implementation of a Bayesian approach to cryo-EM structure determination</article-title>. <source>J. Struct. Biol.</source><year>2012</year>; <volume>180</volume>:<fpage>519</fpage>&#x02013;<lpage>530</lpage>.<pub-id pub-id-type="pmid">23000701</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zivanov</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Nakane</surname><given-names>T.</given-names></string-name>, <string-name><surname>Forsberg</surname><given-names>B.O.</given-names></string-name>, <string-name><surname>Kimanius</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hagen</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Lindahl</surname><given-names>E.</given-names></string-name>, <string-name><surname>Scheres</surname><given-names>S.H.</given-names></string-name></person-group>
<article-title>New tools for automated high-resolution cryo-EM structure determination in RELION-3</article-title>. <source>Elife</source>. <year>2018</year>; <volume>7</volume>:<fpage>e42166</fpage>.<pub-id pub-id-type="pmid">30412051</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Varadi</surname>
<given-names>M.</given-names>
</string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Natassia</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yordanova</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stroe</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>G.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D439</fpage>&#x02013;<lpage>D444</lpage>.<pub-id pub-id-type="pmid">34791371</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Casanal</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Lohkamp</surname><given-names>B.</given-names></string-name>, <string-name><surname>Emsley</surname><given-names>P.</given-names></string-name></person-group>
<article-title>Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data</article-title>. <source>Protein Sci.</source><year>2020</year>; <volume>29</volume>:<fpage>1069</fpage>&#x02013;<lpage>1078</lpage>.<pub-id pub-id-type="pmid">31730249</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Jamali</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Kimanius</surname><given-names>D.</given-names></string-name>, <string-name><surname>Scheres</surname><given-names>S.</given-names></string-name></person-group>
<article-title>ModelAngelo: automated model building in Cryo-EM maps</article-title>. <year>2022</year>; <comment>bioRxiv doi:</comment><comment>8 February 2023, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.48550/arXiv.2210.00006</pub-id>.</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Watson</surname>
<given-names>Z.L.</given-names>
</string-name>, <string-name><surname>Ward</surname><given-names>F.R.</given-names></string-name>, <string-name><surname>Meheust</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ad</surname><given-names>O.</given-names></string-name>, <string-name><surname>Schepartz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Banfield</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Cate</surname><given-names>J.H.</given-names></string-name></person-group>
<article-title>Structure of the bacterial ribosome at 2 &#x000c5; resolution</article-title>. <source>elife</source>. <year>2020</year>; <volume>9</volume>:<fpage>e60482</fpage>.<pub-id pub-id-type="pmid">32924932</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kovalevskiy</surname>
<given-names>O.</given-names>
</string-name>, <string-name><surname>Nicholls</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Long</surname><given-names>F.</given-names></string-name>, <string-name><surname>Carlon</surname><given-names>A.</given-names></string-name>, <string-name><surname>Murshudov</surname><given-names>G.N.</given-names></string-name></person-group>
<article-title>Overview of refinement procedures within REFMAC5: utilizing data from different sources</article-title>. <source>Acta Crystallogr. D Struct. Biol.</source><year>2018</year>; <volume>74</volume>:<fpage>215</fpage>&#x02013;<lpage>227</lpage>.<pub-id pub-id-type="pmid">29533229</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamashita</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Palmer</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Burnley</surname><given-names>T.</given-names></string-name>, <string-name><surname>Murshudov</surname><given-names>G.N.</given-names></string-name></person-group>
<article-title>Cryo-EM single-particle structure refinement and map calculation using Servalcat</article-title>. <source>Acta Crystallogr. D Struct. Biol.</source><year>2021</year>; <volume>77</volume>:<fpage>1282</fpage>&#x02013;<lpage>1291</lpage>.<pub-id pub-id-type="pmid">34605431</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liebschner</surname>
<given-names>D.</given-names>
</string-name>, <string-name><surname>Afonine</surname><given-names>P.V.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Bunkoczi</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>V.B.</given-names></string-name>, <string-name><surname>Croll</surname><given-names>T.I.</given-names></string-name>, <string-name><surname>Hintze</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hung</surname><given-names>L.W.</given-names></string-name>, <string-name><surname>Jain</surname><given-names>S.</given-names></string-name>, <string-name><surname>McCoy</surname><given-names>A.J.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</article-title>. <source>Acta Crystallogr. D Struct. Biol.</source><year>2019</year>; <volume>75</volume>:<fpage>861</fpage>&#x02013;<lpage>877</lpage>.<pub-id pub-id-type="pmid">31588918</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Williams</surname>
<given-names>C.J.</given-names>
</string-name>, <string-name><surname>Headd</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Moriarty</surname><given-names>N.W.</given-names></string-name>, <string-name><surname>Prisant</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Videau</surname><given-names>L.L.</given-names></string-name>, <string-name><surname>Deis</surname><given-names>L.N.</given-names></string-name>, <string-name><surname>Verma</surname><given-names>V.</given-names></string-name>, <string-name><surname>Keedy</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Hintze</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>V.B.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>MolProbity: more and better reference data for improved all-atom structure validation</article-title>. <source>Protein Sci.</source><year>2018</year>; <volume>27</volume>:<fpage>293</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="pmid">29067766</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pettersen</surname>
<given-names>E.F.</given-names>
</string-name>, <string-name><surname>Goddard</surname><given-names>T.D.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>E.C.</given-names></string-name>, <string-name><surname>Couch</surname><given-names>G.S.</given-names></string-name>, <string-name><surname>Croll</surname><given-names>T.I.</given-names></string-name>, <string-name><surname>Morris</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Ferrin</surname><given-names>T.E.</given-names></string-name></person-group>
<article-title>UCSF ChimeraX: structure visualization for researchers, educators, and developers</article-title>. <source>Protein Sci.</source><year>2021</year>; <volume>30</volume>:<fpage>70</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">32881101</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Obana</surname>
<given-names>N.</given-names>
</string-name>, <string-name><surname>Shirahama</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Abe</surname><given-names>K.</given-names></string-name>, <string-name><surname>Nakamura</surname><given-names>K.</given-names></string-name></person-group>
<article-title>Stabilization of <italic toggle="yes">Clostridium perfringens</italic> collagenase mRNA by VR-RNA-dependent cleavage in 5' leader sequence</article-title>. <source>Mol. Microbiol.</source><year>2010</year>; <volume>77</volume>:<fpage>1416</fpage>&#x02013;<lpage>1428</lpage>.<pub-id pub-id-type="pmid">20572941</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Britton</surname>
<given-names>R.A.</given-names>
</string-name>, <string-name><surname>Eichenberger</surname><given-names>P.</given-names></string-name>, <string-name><surname>Gonzalez-Pastor</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Fawcett</surname><given-names>P.</given-names></string-name>, <string-name><surname>Monson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Losick</surname><given-names>R.</given-names></string-name>, <string-name><surname>Grossman</surname><given-names>A.D.</given-names></string-name></person-group>
<article-title>Genome-wide analysis of the stationary-phase sigma factor (sigma-H) regulon of <italic toggle="yes">Bacillus subtilis</italic></article-title>. <source>J. Bacteriol.</source><year>2002</year>; <volume>184</volume>:<fpage>4881</fpage>&#x02013;<lpage>4890</lpage>.<pub-id pub-id-type="pmid">12169614</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Orelle</surname>
<given-names>C.</given-names>
</string-name>, <string-name><surname>Carlson</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kaushal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Almutairi</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ochabowicz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pham</surname><given-names>V.C.</given-names></string-name>, <string-name><surname>Squires</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>B.T.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Tools for characterizing bacterial protein synthesis inhibitors</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2013</year>; <volume>57</volume>:<fpage>5994</fpage>&#x02013;<lpage>6004</lpage>.<pub-id pub-id-type="pmid">24041905</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Stabler</surname>
<given-names>R.A.</given-names>
</string-name>, <string-name><surname>He</surname><given-names>M.</given-names></string-name>, <string-name><surname>Dawson</surname><given-names>L.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>M.</given-names></string-name>, <string-name><surname>Valiente</surname><given-names>E.</given-names></string-name>, <string-name><surname>Corton</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lawley</surname><given-names>T.D.</given-names></string-name>, <string-name><surname>Sebaihia</surname><given-names>M.</given-names></string-name>, <string-name><surname>Quail</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Comparative genome and phenotypic analysis of <italic toggle="yes">Clostridium difficile</italic> 027 strains provides insight into the evolution of a hypervirulent bacterium</article-title>. <source>Genome Biol.</source><year>2009</year>; <volume>10</volume>:<fpage>R102</fpage>.<pub-id pub-id-type="pmid">19781061</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Roberts</surname>
<given-names>A.P.</given-names>
</string-name>, <string-name><surname>Smits</surname><given-names>W.K.</given-names></string-name></person-group>
<article-title>The evolving epidemic of <italic toggle="yes">Clostridium difficile</italic> 630</article-title>. <source>Anaerobe</source>. <year>2018</year>; <volume>53</volume>:<fpage>2</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">29730161</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lai</surname>
<given-names>C.J.</given-names>
</string-name>, <string-name><surname>Weisblum</surname><given-names>B.</given-names></string-name></person-group>
<article-title>Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1971</year>; <volume>68</volume>:<fpage>856</fpage>&#x02013;<lpage>860</lpage>.<pub-id pub-id-type="pmid">5279527</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Leclercq</surname>
<given-names>R.</given-names>
</string-name>, <string-name><surname>Courvalin</surname><given-names>P.</given-names></string-name></person-group>
<article-title>Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification</article-title>. <source>Antimicrob. Agents Chemother.</source><year>1991</year>; <volume>35</volume>:<fpage>1267</fpage>&#x02013;<lpage>1272</lpage>.<pub-id pub-id-type="pmid">1929280</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zuker</surname>
<given-names>M.</given-names>
</string-name>
</person-group>
<article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>; <volume>31</volume>:<fpage>3406</fpage>&#x02013;<lpage>3415</lpage>.<pub-id pub-id-type="pmid">12824337</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Farnham</surname>
<given-names>P.J.</given-names>
</string-name>, <string-name><surname>Platt</surname><given-names>T.</given-names></string-name></person-group>
<article-title>Rho-independent termination: dyad symmetry in DNA causes RNA polymerase to pause during transcription in vitro</article-title>. <source>Nucleic Acids Res.</source><year>1981</year>; <volume>9</volume>:<fpage>563</fpage>&#x02013;<lpage>577</lpage>.<pub-id pub-id-type="pmid">7012794</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gusarov</surname>
<given-names>I.</given-names>
</string-name>, <string-name><surname>Nudler</surname><given-names>E.</given-names></string-name></person-group>
<article-title>The mechanism of intrinsic transcription termination</article-title>. <source>Mol Cell</source>. <year>1999</year>; <volume>3</volume>:<fpage>495</fpage>&#x02013;<lpage>504</lpage>.<pub-id pub-id-type="pmid">10230402</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sipos</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Szigeti</surname><given-names>R.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>X.</given-names></string-name>, <string-name><surname>Turnbough</surname><given-names>C.L.</given-names><suffix>Jr.</suffix></string-name></person-group>
<article-title>Systematic mutagenesis of the thymidine tract of the <italic toggle="yes">pyrBI</italic> attenuator and its effects on intrinsic transcription termination in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>Mol. Microbiol.</source><year>2007</year>; <volume>66</volume>:<fpage>127</fpage>&#x02013;<lpage>138</lpage>.<pub-id pub-id-type="pmid">17725561</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yarnell</surname>
<given-names>W.S.</given-names>
</string-name>, <string-name><surname>Roberts</surname><given-names>J.W.</given-names></string-name></person-group>
<article-title>Mechanism of intrinsic transcription termination and antitermination</article-title>. <source>Science</source>. <year>1999</year>; <volume>284</volume>:<fpage>611</fpage>&#x02013;<lpage>615</lpage>.<pub-id pub-id-type="pmid">10213678</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Takamizawa</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Miyata</surname><given-names>S.</given-names></string-name>, <string-name><surname>Matsushita</surname><given-names>O.</given-names></string-name>, <string-name><surname>Kaji</surname><given-names>M.</given-names></string-name>, <string-name><surname>Taniguchi</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tamai</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shimamoto</surname><given-names>S.</given-names></string-name>, <string-name><surname>Okabe</surname><given-names>A.</given-names></string-name></person-group>
<article-title>High-level expression of clostridial sialidase using a ferredoxin gene promoter-based plasmid</article-title>. <source>Protein Expr Purif.</source><year>2004</year>; <volume>36</volume>:<fpage>70</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">15177286</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Czepiel</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Drozdz</surname><given-names>M.</given-names></string-name>, <string-name><surname>Pituch</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kuijper</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Perucki</surname><given-names>W.</given-names></string-name>, <string-name><surname>Mielimonka</surname><given-names>A.</given-names></string-name>, <string-name><surname>Goldman</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wultanska</surname><given-names>D.</given-names></string-name>, <string-name><surname>Garlicki</surname><given-names>A.</given-names></string-name>, <string-name><surname>Biesiada</surname><given-names>G.</given-names></string-name></person-group>
<article-title>
<italic toggle="yes">Clostridium difficile</italic> infection: review</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2019</year>; <volume>38</volume>:<fpage>1211</fpage>&#x02013;<lpage>1221</lpage>.<pub-id pub-id-type="pmid">30945014</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Martin</surname>
<given-names>J.S.</given-names>
</string-name>, <string-name><surname>Monaghan</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Wilcox</surname><given-names>M.H.</given-names></string-name></person-group>
<article-title>Clostridium difficile infection: epidemiology, diagnosis and understanding transmission</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2016</year>; <volume>13</volume>:<fpage>206</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">26956066</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Davis</surname>
<given-names>A.R.</given-names>
</string-name>, <string-name><surname>Gohara</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Yap</surname><given-names>M.N.</given-names></string-name></person-group>
<article-title>Sequence selectivity of macrolide-induced translational attenuation</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2014</year>; <volume>111</volume>:<fpage>15379</fpage>&#x02013;<lpage>15384</lpage>.<pub-id pub-id-type="pmid">25313041</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kannan</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Kanabar</surname><given-names>P.</given-names></string-name>, <string-name><surname>Schryer</surname><given-names>D.</given-names></string-name>, <string-name><surname>Florin</surname><given-names>T.</given-names></string-name>, <string-name><surname>Oh</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bahroos</surname><given-names>N.</given-names></string-name>, <string-name><surname>Tenson</surname><given-names>T.</given-names></string-name>, <string-name><surname>Weissman</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Mankin</surname><given-names>A.S.</given-names></string-name></person-group>
<article-title>The general mode of translation inhibition by macrolide antibiotics</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2014</year>; <volume>111</volume>:<fpage>15958</fpage>&#x02013;<lpage>15963</lpage>.<pub-id pub-id-type="pmid">25349425</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Seip</surname>
<given-names>B.</given-names>
</string-name>, <string-name><surname>Sacheau</surname><given-names>G.</given-names></string-name>, <string-name><surname>Dupuy</surname><given-names>D.</given-names></string-name>, <string-name><surname>Innis</surname><given-names>C.A.</given-names></string-name></person-group>
<article-title>Ribosomal stalling landscapes revealed by high-throughput inverse toeprinting of mRNA libraries</article-title>. <source>Life Sci. Alliance</source>. <year>2018</year>; <volume>1</volume>:<fpage>e201800148</fpage>.<pub-id pub-id-type="pmid">30456383</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Syroegin</surname>
<given-names>E.A.</given-names>
</string-name>, <string-name><surname>Aleksandrova</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Polikanov</surname><given-names>Y.S.</given-names></string-name></person-group>
<article-title>Structural basis for the inability of chloramphenicol to inhibit peptide bond formation in the presence of A-site glycine</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>7669</fpage>&#x02013;<lpage>7679</lpage>.<pub-id pub-id-type="pmid">35766409</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Polikanov</surname>
<given-names>Y.S.</given-names>
</string-name>, <string-name><surname>Steitz</surname><given-names>T.A.</given-names></string-name>, <string-name><surname>Innis</surname><given-names>C.A.</given-names></string-name></person-group>
<article-title>A proton wire to couple aminoacyl-tRNA accommodation and peptide-bond formation on the ribosome</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2014</year>; <volume>21</volume>:<fpage>787</fpage>&#x02013;<lpage>793</lpage>.<pub-id pub-id-type="pmid">25132179</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Koller</surname>
<given-names>T.O.</given-names>
</string-name>, <string-name><surname>Turnbull</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Vaitkevicius</surname><given-names>K.</given-names></string-name>, <string-name><surname>Crowe-McAuliffe</surname><given-names>C.</given-names></string-name>, <string-name><surname>Roghanian</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bulvas</surname><given-names>O.</given-names></string-name>, <string-name><surname>Nakamoto</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Kurata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Julius</surname><given-names>C.</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>G.C.</given-names></string-name><etal>et al</etal>.</person-group>
<article-title>Structural basis for HflXr-mediated antibiotic resistance in <italic toggle="yes">Listeria monocytogenes</italic></article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>11285</fpage>&#x02013;<lpage>11300</lpage>.<pub-id pub-id-type="pmid">36300626</pub-id></mixed-citation></ref></ref-list></back></article>